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Infection by M. tuberculosis results in an estimated 1.7 million TB related deaths worldwide. 
Mycothiol is produced in M. tuberculosis as the dominant low molecular weight thiol and is 
thought to protect the bacteria against oxidative stress. Since mycothiol is unique to 
Actinomycetes and is also proposed to play an important role in the dormant state of 
Mycobacteria, the pseudo-dissacharide is seen as a potential target for novel anti-tuberculars. 
Targeting the mycothiol redox cycle has led to MshB inhibition by a series of substrate 
analogues. These inhibitors comprise plumbagin conjugated to a phenyl thioglycoside via an 
alkyl chain of variable length. Kinetics studied showed that the competitive inhibition increased 
when the alkyl linker was lengthened. The binding of the inhibitors was investigated using 
computational techniques in order to rationalise the observed trend in inhibition. 
 
The binding of the MshB natural substrate, 1-D-myo-inosityl-2-acetamido-2-deoxy-α-D-
glucopyranoside (GlcNAc-Ins), is unconfirmed in the literature. Therefore, the MshB active site 
was characterised and the enzyme was docked with GlcNAc-Ins. Atomistic molecular dynamics 
(MD) simulations were then used to identify key interactions. The GlcNAc binding mode was 
used as a template for docking the substrate-based inhibitors. Key interactions between MshB 
and the inhibitors were elucidated using MD, and the validity of the model was tested using free 
energy methods. The ranking of the inhibitor series based on their relative free energy of binding 
was compared with experimental inhibition constants. The free energy calculations showed that 
the binding of the linker and plumbagin does not occupy a hydrophobic cavity adjacent to the 
putative active site, but rather a kink in the alkyl chain directs the plumbagin towards the active 
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1.1. MYCOTHIOL AS A TARGET FOR NOVEL ANTI-
TUBERCULARS  
1.1.1. TUBERCULOSIS 
Tuberculosis (TB) is a highly contagious disease caused by Mycobacterium tuberculosis [1]. The 
symptoms of active TB are coughing blood with sputum, chest pains, weakness, weight loss, 
fever and night sweats. It is estimated that one-third of the world’s population is infected with TB 
bacilli [1], which are transmitted via droplets from the throat and lungs of hosts with the active 
respiratory disease. Once inhaled into the lung the bacteria are phagocytosed by alveolar 
macrophages and induce an inflammatory response (Figure 1-1). Mononuclear cells from 
neighbouring blood vessels are recruited and form the building blocks for a granulum (or 
tubercule). In the containment phase non-replicating M. tuberculosis cells lie dormant within the 
granuloma and the host displays no symptoms. When the host’s immune system is compromised 
the granuloma ruptures and spills thousands of viable, infectious bacilli into the airways. Such a 
change in the immune status is one which reduces the number, or impairs the function of CD4
+ 
T 
cells [2]. Thus active TB has a close association with age, malnutrition and acquired 
immunodeficiency deficiency virus (AIDS) [1]. TB has been classified by the World Health 
Organisation (WHO) as a pandemic and in 2009 the disease resulted in an estimated 1.7 million 
deaths worldwide [3]. TB is most prevalent in Asia and southern Africa. In 2009 South Africa 













Traditionally TB has been treated by a six month course of isoniazid and rifampicin which are 
known as first-line drugs. Partial or inconsistent treatment of TB has led to antibiotic resistance in 
M. tuberculosis and the emergence of multidrug-resistant TB (MDR-TB
1
) and extensively drug-
resistant TB (XDR-TB
2
). Treatment of these cases require extensive chemotherapy using drugs 
that are costlier and more toxic than the first line drugs [1, 4]. MDR-TB and XDR-TB are a 
serious emerging threat to global public health, especially, in countries with a high prevalence of 
                                                 
1  MDR-TB is defined as TB resistant to the two main first-line drugs (isoniazid and rifampicin) 
2  XDR-TB is defined as TB resistant to multiple drugs as well as to any one of the flouroquinolone drugs and 
to at least one of the three injectable second-line drugs (amikacin, capreomycin or kanamycin) 
 












the human immunodeficiency virus (HIV). In 2009 South Africa had the fourth largest number of 
estimated cases of XDR-TB (13 000) behind China, India and the Russian Federation [3].  
 
It is feared that XDR-TB could replace the current TB epidemic of mostly drug-susceptible TB 
with a form of TB with severely restricted treatment options [4]. In 2006, WHO launched the 
new STOP TB Strategy which aims to reverse the incidence of TB by 2015 and eliminate TB as a 
public health problem by 2050. A key point of this strategy is the research and development of 
new diagnostics, drugs and vaccines against drug resistant strains [1].  
 
Thus, development of a new treatment for TB has become an international priority. Furthermore, 
effectiveness against latent M. tuberculosis is considered a prime criterion for new tuberculosis 
drugs [5]. Many drugs that are lethal to growing M. tuberculosis cells fail to kill the bacterium in 
the latent or dormant state (non-replicating and persistant). When treatment is discontinued 
reactivation can result in a further episode of active tuberculosis. In this context, there has been 
much focus on mycothiol as a target for novel anti-tuberculars.  
 
 
1.1.2. MSH: STRUCTURE, DISTRIBUTION AND FUNCTION 
STRUCTURE AND BIOSYNTHESIS 
Mycothiol (MSH, Figure 1-2), or 1-O-[2-[(2R)-2-acetamido-3-mercaptopropanamido]-2-deoxy-
α-D-glucopyranosyl]-D-myo-inositol, comprises a cysteine residue in which the amino group is 
acetylated and the carboxyl group is linked by a unique amide bond to D-glucosamine, which is 
in turn α(1-1) linked to D-myo-inositol. MSH has been found to occur only in Actinobacteria, the 
class which includes M. tuberculosis, where it is mostly produced as the dominant low-
molecular-weight (LMW) thiol [5]. MSH cycles between its reduced and oxidised disulfide 




 ⇌ 2MSH), but the reducing action of the constitutively active MSH-













The biosynthetic pathway for MSH has been elucidated and is presented in Figure 1-2. 
Measurement of thiol levels in M. smegmatis mutants with targeted disruptions in each of mshA, 
mshB, mshC and mshD have shown that MshA and MshC are essential to MSH biosynthesis in 
Mycobacteria [5]. On the other hand the M. tuberculosis mshB mutant produced 20% of normal 
MSH levels during exponential growth, but showed increased levels over the wild-type with 
prolonged culture [7]. This indicates that the cell contains an additional activity capable of 
deacetylating GlcN-Ins. The M. tuberculosis mshD::Tn5 mutant produced ~1% of normal MSH 
levels by transacetylation of Cys-GlcN-Ins by acetyl-CoA, but formyl-GlcN-Ins was detected at 
high yields and may partially substitute for MSH in MshD-deficient mutants [8].  
 
FUNCTION OF MSH IN M. TUBERCULOSIS 
Many of the functions of MSH in Actinobacteria have been extrapolated by analogy to 
glutathione (GSH), which is the major LMW thiol in most other organisms [6, 9]. Comparison 
 
FIGURE 1-2 Biosynthesis of MSH. Initially 1L-myo-inositol-1-phosphate is produced from glucose-6-phosphate by inositol phosphate 
synthase (Ino1). MSH biosynthesis is then accomplished in five steps. The enzymes involved in the five-step pathway 
include a glycosyltransferase (MshA), a phosphatase (MshA2), a deacetylase (MshB), an ATP-dependent ligase (MshC), 












with GSH suggests that MSH serves as the major cellular redox buffer and helps to maintain an 
effective reducing environment within the cell. This is essential for metabolism in aerobic cells 
and the redox status must be maintained in the face of the oxidising threat from metabolic 
intermediates. M. tuberculosis must also protect itself against the highly oxidising extracellular 
environment of host macrophages, which has been shown to make the boundary to the central 
region of granulomas hypoxic [2]. The retaining mechanisms of MSH are not fully known, but it 
is understood that high concentrations of the thiol form (maintained through the action of Mtr) 
makes a large contribution to the reducing environment [5, 6]. Further MSH-dependent 
mechanisms that protect the M. tuberculosis cells from oxidation stress include: detoxifying 
reactive oxygen and nitrogen species; detoxifying electrophillic xenobiotics; and serving as a 
reservoir of stabilised cysteine that is less susceptible to metal catalysed auto-oxidation and 
resultant hydrogen peroxide formation [5, 6]. The activities of the well characterised MSH-
dependent enzymes are summarised in Figure 1-3. It has been shown that MSH S-conjugate 
Amidase, Mca, may play an important role in drug resistance of M. tuberculosis [6, 9]. The 
enzyme does so by cleaving conjugates of MSH and thiol-reactive drugs (MSR in Figure 1-3), 
and excreting the mercapturic acid produced.  
 
 
1.1.3. MSH AS A DRUG TARGET 
A key trait of a drug target is its essentiality to the pathogen. Hence, the presence of MSH as the 
dominant thiol in M. tuberculosis has sparked much interest in the pseudo-disaccharide as a 
target for novel anti-tuberculars. Although MSH plays an important function as redox buffer, it is 
still unclear as to whether it is in fact essential [5]. Early attempts that were unsuccessful in 
isolating M. tuberculosis MSH-free mutants by a targeted disruption in mshA [10] and mshC [11] 
led to the conclusion that the thiol is needed for growth. Recently, however MshD mutants have 
been reported [12, 13] and cast doubt on the previous assertions [5]. Nevertheless, targeting the 
redox cycling of MSH remains an important drug-discovery strategy.  
 
Recently a study has shown that most bactericidal antibiotics ultimately act by generating 












stress, the MSH redox pathway appears to be a good target for combinatorial chemotherapy with 
existing antibiotics. Indeed, Mycobacterial MSH mutants have been shown to be more sensitive  
to a number of antibiotics including erythromycin, azithromycin, penicillin G and vancomycin 
[15]. Several other factors highlight MshB as an important drug target: 
 
 Chemotherapy: Since there is no mammalian counterpart to the MSH pathway it should 
be possible to achieve selective inhibition of MSH biosynthesis and metabolism. 
 
 Targeting antibiotic resistance: S-conjugation and subsequent action of Mca has been 
identified as a possible source of antibiotic resistance [5, 6]. MSH inhibition could inhibit 
this activity allowing efficacy of existing first line antibiotics.  
 
 Targeting of dormant state: The significant increase in MSH levels observed in M. 
tuberculosis cultures in the transition from log to stationary phase suggests that MSH may 
be required for M. tuberculosis in attaining a state of dormancy. Furthermore, there is 
evidence that the enzymes of MSH biosynthesis and metabolism are active in the dormant 
state [5, 6]. Drugs targeting MSH may be effective against dormant tuberculosis, which 
has been identified as an important goal for novel anti-tuberculars. 
 
In targeting the MSH pathway in order to develop novel anti-tubercular drugs, lead compounds 
should inhibit MSH biosynthesis and/or the MSH-dependent enzymes that are critical to the 
 













survival of replicating and dormant cells of M. tuberculosis. The former strategy would 
simultaneously inactivate all MSH-dependent metabolic processes. Therefore, the biosynthetic 
enzymes that are essential for MSH production, namely MshA and MshC, are prime targets. 
However, the search for drugs directed against them has been limited by the inability to readily 
generate active, purified protein, and by lack of available crystal structures [5, 6]. MshB and 
MshD are less promising [5, 6], since mutants with targeted disruptions in mshA and mshD do not 
represent MSH-free states. Nevertheless, as explained above, reducing MSH levels in M. 
tuberculosis cells may still yield the pathogen susceptible to antimicrobial factors of the host 
immune response and antibiotics. This hypothesis is supported by research which showed that a 
MshD mutant of M. tuberculosis failed to grow in cultures of primary murine macrophages that 
modelled the host immune response. Thus, MshA and MshB remain potential drug targets, 
especially if relevant drugs were administered in combination with known bactericidal 
antibiotics. Research into targeting the MSH redox pathway has focused on the design of 




1.2.1. CRYSTAL STUCTURE 
GlcNAc-Ins N-deacetylase or MshB is the third enzyme in the MSH biosynthetic pathway and 
catalyses hydrolysis of the N-acetyl amide bond of GlcNAc-Ins to give the free amino sugar 
GlcN-Ins. MshB has also been shown to have overlapping amidase activity with Mca, although 
the rate of amide cleavage is significantly lower in MshB for most substrates [5].  
 
Two crystal structures of M. tuberculosis MshB have been reported [16, 17]. The first structure, 
solved by James et al. (1Q74) [16], contains four protein molecules in the unit cell and the 
topology of Molecule A is given in Figure 1-4. In the tertiary structure a nine-stranded mixed β- 












core β-sheet, together with helices α1 through to α5, adopt a supersecondary structure similar to 
the Rosman fold. A three-stranded anti-parallel β-sheet (β7, β8, β9) forms a subdomain with α7. 
His13 from the loop linking β1 and α1, Asp16 from the C-terminus of β1 and His147 from the N-
terminus of helix α5 comprise a zinc-binding site. The holoenzyme showed two water molecules 
that coordinate to the Zn
2+
 ion (Figure 1-5B). Molecule A is the most complete structure from 
1Q74 but is missing residues 1-2, 100-103, 164-169, 300-303. Baker et al. have also published a 
crystal structure (1Q7T) [17] in which the first of two molecules in the asymmetric unit is 
missing only the loop formed by residues 165-170 (Figure 1-5). β-octylglucoside, used in the 
crystallisation process, was co-crystallised near the zinc binding site and its binding is illustrated 
in Figure 1-6A. The β-octyl glucoside is an analogue of the glucose unit in the natural substrate, 
and was used to model GlcNAc binding in accordance with the proposed catalytic mechanism 
discussed below (Section 1.2.2, Figure 1-6C). In this model a zinc binding site consistent with 




. The authors 
were then able to build a 2-C-acetylamido group onto the BOG template such that the carbonyl 
was coordinated to the zinc. The resulting orientation of GlcNAc is illustrated in (Figure 1-6B).  
 
The sugar binding is mediated by hydrogen bonding. The oxygens of O3 and O4 are hydrogen 
bonded to Arg68, while the hydrogens at O4 and O6 are hydrogen bonded to the carboxylate of 
Asp95. A hydrogen bond is also modelled between His144 and the oxygen at O6.  
 
 
FIGURE 1-4 Secondary structure of MshB 1Q74. The green circle denotes the location of two of the zinc binding ligands (His13 and 

















FIGURE 1-5 (A) Surface representation of the crystal structure of molecule A in 1Q74. The catalytic zinc is shown as a wheat coloured 
sphere. (B) Molecule A illustrated in cartoon representation with the same angle of view as Figure 1-5A. The catalytic zinc 
is shown as a wheat coloured sphere. The circle indicates the position of the loop comprising residues 164-170 which is 
missing in this structure and in 1Q7T. (C) The zinc-binding pocket is magnified and shows the two zinc coordinated 















1.2.2. CATALYTIC MECHANISM AND NATURAL SUBSTRATE 
BINDING  
MshB is a zinc-dependent deacetylase. Typically the catalytic mechanism of this class of 
enzymes follows nucleophillic attack of a zinc-coordinated water with zinc stabilisation of the 
intermediate and general-acid-base catalysis (GABC) [18].  
 
A catalyst increases the rate of a reaction by decreasing the free energy of the transition state. In 
general acid catalysis this is achieved by partial proton transfer from an acid, while in general 
base catalysis the free energy of the transition state is lowered by partial proton abstraction by a 
base [19]. When both processes are present the catalysis is referred to as GABC. Enzymes are 
well suited to GABC since several catalytic residues (either acidic or basic) can be arranged 
around the substrate. In a large number of cases, the mechanism of zinc-dependent deacetylases 
is initiated with a basic residue partially abstracting a hydrogen from a zinc-coordinated water 
[18]. The water then undergoes a nucleophillic attack on the acetyl carbonyl group of the 
substrate. Finally, an acidic residue transfers a proton to the resulting tetrahedral intermediate to 
promote conversion to the deacetylated product and acetic acid. There are two types of GABC 
mechanisms. In the first mechanism a single bifunctional residue serves as the basic residue and 
once protonated can function as the acidic residue. In the second mechanism a pair of amino 
acids provide the acid base catalysis. 
 
The proposed GABC mechanism for MshB includes a GABC pair and is shown in Figure 1-6C. 
The mechanism is based on the similarity of the active site residues in MshB with those found in 
well characterised metalloproteases. It is postulated that the substrate binds to the active site, so 
that the carbonyl oxygen of the N-acetyl coordinates to the Zn
2+
 cation, and displaces a water 












tetrahedral intermediate which is stabilised by zinc coordination and a purported interaction with 
the positively charged histidine residue. Finally, proton transfer from protonated Asp15 to the 
amine leaving-group facilitates the collapse of the tetrahedral intermediate with resultant 
cleavage of the C-N bond. In this mechanism, Asp15 acts as a single acid base pair. Hernick and 







FIGURE 1-6 (A) Binding orientation of the β-octyl glucoside co-crystallised near the zinc-binding site in 1Q74. (B) Binding of the 
GlcNAc fragment from the natural substrate. Binding is modelled using the BOG crystal structure and proposed catalytic 
mechanism. Illustration taken from Baker et al.[17] . (C) Proposed catalytic mechanism for deacetylase action of MshB. 
The mechanism was proposed based on structural similarity with the other metalloproteases. Figure adapted from Fierke 














acetylglucosamine deacetylase makes it possible that MshB could function via a GABC pair with 
His144 transferring its proton to the amino sugar during the collapse of the tetrahedral 
intermediate [18]. Additional site mutagenesis and kinetics experiments are needed for clarity on 
the catalytic mechanism.  
 
The binding of the natural substrate, GlcNAc-Ins, also remains uncertain. Binding of the GlcNAc 
fragment has been modelled based on the BOG crystal structure. As mentioned previously, this 
model was generated by building an acetyl group onto BOG so that it displayed coordination 
geometry with Zn
2+
 that was consistent with the proposed catalytic mechanism (Figure 1-6C). 
Subsequently, in a study of the inhibitory activity of bromotyrosine-derived compounds, 
GlcNAc-Ins was docked with MshB [20]. Bewley and co-workers obtained a low-energy cluster 
of solutions which had GlcNAc geometries that were close to the BOG model. However, no 
crystal structure has been reported in which an inhibitor or substrate analogue is coordinated to 
the MshB zinc ion. Furthermore, the above models do not describe interactions of the inositol and 
acetyl methyl moieties which are critical features for substrate recognition [5, 6]. A 70-fold  
decrease in rate of deacetylation is observed when the inositol was removed, and turnover rate of 
MSH, which has an AcCys at the glucose C-2 position, proceeds 330 times slower than GlcNAc-
Ins [21]. The stereochemical configuration of the inositol also has a significant impact on 
selectivity and MshB is unable to turnover GlcNAc-L-Ins [22].  
 
1.3. PLUMBAGIN CONJUGATES AS INHIBITORS OF 
MSHB 
Recent investigtion into targeting the MSH redox pathway has led to the design and preparation 
of a set of subversive substrates of Mtr, 1a-1d (Figure 1-7) [23]. A phenylthioglycoside was 
tethered to plumbagin in an effort to confer specificity of the naphthoquinone to redox cycling of 
Mtr over other NAD(P)H reductases. Although the compounds synthesised were much poorer 
substrates of Mtr than plumbagin itself, it was found that the series of substituted 













TABLE 1-1   Percentages of MshB and Mca inhibition by plumbagin conjugates. 
Substrate Mca MshB 
1a 28.8 57.4 
1b 37.8 81.6 
1c 23.2 81.4 
1d 44.5 94.8 
 
Percentage inhibition of the hydrolysis of the substrates MSmB and GlcNac-Ins by Mca and MshB respectively, was 
determined at substrate and inhibitor concentrations of 250μM each for Mca and 500μM each for mshB. Table 
excerpted from Gammon et al. [22].  
 
 
level. Kinetic studies showed th  inhibition by the series of naphthoquinones to be competitive 
and constants for 1a, 1c and 1d were estimated to be to be 167 + 15μM, 94 + 11 μM and 16.8 + 
1.9μM, respectively. Two interesting observations arise from these results. 
 
Firstly, the Ki values of the naphthoquinones indicate that their binding affinity increases with the 
length of the spacer. The inhibition constant, Ki, is the dissociation constant of the enzyme 
inhibitor complex, and is a measure of the strength of the enzyme-inhibitor complex: a high Ki 
indicates a weak binding and a low Ki indicates strong binding [19]. Preliminary docking studies 
were undertaken to understand how the spacer length improves the binding affinity of 1a-1d. The 
conformations of 1a and 1d showed that the longer carbon chain of 1d extends the hydrophobic 
 












naphthoquinone group facilitating favourable nonpolar interactions with the dipeptide of Val 184 
and Leu 185 [23]. 
 
Gammon et al. [23] also compared the inhibition constants with the KM value of 1.695±0.151mM 
for phenyl-2-acetamido-2-deoxy-1-thio-α-D-glucopyranoside. The KM value is numerically equal 
to the substrate concentration at which the rate of conversion is half of vmax and like the Ki a small 
value indicates a high substrate affinity. Such a large difference between the Ki and KM values 
show that the naphthoquinone significantly improves that affinity to the active site. 
 
It is pertinent to understand the MshB active site and explore inhibitor binding more 
comprehensively so that the potential drug lead of the substrate-based inhibitors can be rationally 
developed. Computational chemistry provides computer based methods for understanding and 
predicting the behaviour of such a molecular system. 
 
1.4. OBJECTIVES 
The primary objective of this thesis is to rationalise the trend observed for MshB inhibition by 
1a-1d (Figure 1-7). Since inhibition is competitive, relative free energies of binding were 
calculated to investigate the trend in terms of binding strength.  
 
Neither substrate analogue nor inhibitor has been co-crystallised in the MshB active site. 
Therefore, the first objective of this thesis is to describe the binding of the natural substrate. This 
required prior characterisation of the active site. CASTp was used to identify the MshB binding 
cavity, and the chemical property of the cavity was evaluated by identifying the residues lining 
the surface and calculating the electrostatic surface potential (Chapter 4). Once this had been 
completed the natural substrate, GlcNAc-Ins, was docked and key interactions of the GlcNAc-














The next objectives of this thesis are to identify the favourable conformations of the inhibitors in 
solution, and to simulate the inhibitor series bound to the MshB active site. In order to achieve 
this, a parameterised force field was required. The CHARMM-27-consistent force field employed 
here did not contain parameters for the plumbagin moiety or the dihedrals of the phenyl 
thioglycoside of the inhibitor series. These parameters were calculated from quantum mechanics 
(QM) calculations, before a Principal Component Analysis (PCA) was conducted on the 
dynamics of the inhibitors in solution (Chapter 5). The inhibitors were then docked with MshB 
and the complexes equilibrated using MD simulations.  
 
The final objectives of this thesis are to validate the force field against experimental data and 
describe the inhibitor binding mode. For this purpose relative free energies of binding were 
computed, and the inhibitors ranked accordingly (Chapter 5). Key interactions were also 
identified from the MD trajectories (Chapter 5). 
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COMPUTER SIMULATION METHODS 
The inhibition of MshB by a series of plumbagin conjugates has been described in Chapter 1. To 
develop this anti-tubercular lead it is important to understand the mode of inhibition. Although 
kinetic studies indicated that the inhibition was competitive, attempts at co-crystallisation have 
been unsuccessful. Therefore, the binding and mode of inhibition remain unknown.  
 
Computational methods can be used to quantify the properties of a system at a microscopic scale 
and on a time scale that is otherwise inaccessible. Furthermore, if the model used is validated 
against experimentally determined properties, that model may be used to predict unknown or 
unmeasurable quantities. Simulation of a molecular system is achieved using Monte Carlo (MC) 
or Molecular Dynamics (MD) simulations to generate a set of configurations from which 
properties of the system are calculated by the application of statistical mechanics. MD 
simulations create a time evolution of systems by solving Newton’s equations of motion, and 
have the advantage that time dependent properties can be calculated from the resultant 
trajectories. In order to solve Newton’s equations of motion the forces acting on the particles of 
the system need to be derived from the potential energy. The energy landscape of molecular 
systems can be modelled using Quantum Mechanic (QM) or Molecular Mechanic (MM) 
methods. While solving the Schrödinger equation gives a complete description of systems at an 
atomic and molecular scale, such calculations are not feasible for large systems. MM ignores 
electronic motions and calculates the energy as a function of nuclear coordinates only. Models 
consist of spherical atoms connected by springs and the inter-atomic forces are described by 
simple mathematical functions. 
 
In this thesis QM methods were used for parameterisation of a CHARMM27-consistent force 
field which was employed in the MD simulations of the inhibitor-water and inhibitor-MshB 












approaches (discussed in Chapter 3) to quantify the stability and the free energy differences of the 
molecular systems. The free energy differences were compared with experimentally determined 
inhibition constants to ascertain the validity of the modelled binding. 
 
 
2.1. ELECTRONIC STRUCTURES OF MOLECULES 
2.1.1. QUANTUM MECHANICS OF PARTICLES 
In quantum mechanics the wave-particle duality is reconciled, and the practical mathematics of 
waves are used to describe a particle distribution [1-3]. The particle is described mathematically 
using a wavefunction, Ψ, which is dependent on time and the position of a particle. The 
wavefunctions of the particle and its corresponding energy can be calculated by solving the time-




∇2 + 𝑉 Ψ 𝒓, 𝑡 = 𝑖ħ
𝜕Ψ(𝒓, 𝑡)
𝜕𝑡










                                                                                                    
Equation (2.1) refers to a molecule of mass m which is moving through space (given by a 
position vector r) and time t under the influence of an external field V. This equation can be 
simplified using a number of postulates. When V is independent of time then the molecular 
wavefunction can be described in terms of a spatial wavefunction [1, 2]: 
Ψ 𝒓, 𝑡 = Ψ 𝒓 τ(𝑡)                                                                                                                                                  (2.2) 
This enables solution of the time independent Schrödinger equation: 
ĤΨ 𝒓 = 𝐸Ψ 𝒓                                                                                                                                                         (2.3) 
Ĥ =  −
ħ2
2𝑚












2.1.2. QUANTUM MECHANICS OF MOLECULES 
Molecules can be described mathematically by a molecular wavefunction, which is dependent on 
time, and positions of the nuclei and electrons. The wavefunctions and their corresponding 
energies can then be calculated by solving the time-independent Schrödinger equation: 
𝐻Ψ 𝑹1 , 𝑹2 …𝑹𝑁 , 𝒓1 , 𝒓2 …𝒓𝑛 = 𝐸Ψ 𝑹1 , 𝑹2 …𝑹𝑁 , 𝒓1 , 𝒓2 …𝒓𝑛                                                                   (2.4) 
where r is the position vector of the n electrons and R the position vector describing the N nuclei. 
The Hamiltonian contains all operators that describe the kinetic and potential energy of the 
system. The exact Schrödinger equation can be solved for only a small number of simple systems 
for which boundary conditions have been applied [1-3]. However, a number of approximations 
can be made to make the mathematics of solving the Schrödinger equation for molecules 
tractable. One such approximation is the Born-Oppenheimer approximation, which postulates 
that since electrons are much lighter than nuclei, they can instantaneously respond to any changes 
in the relative positions of the nuclei. This allows separation of the total wavefunction into an 
electronic wavefunction and a nuclear wavefunction: 
Ψ 𝑹1 , 𝑹2 …𝑹𝑁 , 𝒓1 , 𝒓2 …𝒓𝑛 = Φ 𝑹1 , 𝑹2 …𝑹𝑁   𝜓 𝒓1 , 𝒓2 …𝒓𝑛                                                                   (2.5) 
The Born-Oppenheimer approximation introduces negligible error with the exception of excited 
states in polyatomic molecules and ground states of cations [1, 2]. The positions of the nuclei can 
now be fixed and then only the electronic part of the Schrödinger equation needs be solved using 
the appropriate Hamiltonian. The non-relativistic Hamiltonian for the electronic part of the 
Schrödinger equation given in atomic units is: 















In Equation (2.6) i  and j index the electrons, upper case I indexes the N nuclei, and r is a distance 












electron operator. To compensate for spin-dependent terms which are relativistic in origin it is 
necessary to introduce electron spin as a quantum effect [1]. Each electron has a spin quantum 
number of 1/2, and can occupy one of two possible states of alignment under an external 
magnetic field, either spin up (α) or spin down (β). 
 
There are two primary quantum mechanical theories for the description of this electronic 
structure, valence-bond theory (VB theory) and molecular orbital theory (MO theory) [3]. In VB 
a covalent bond is formed between two atoms by overlap of their half-filled valence atomic 
orbitals. MO, on the other hand theorises that electrons do not belong to particular bonds but are 
spread throughout the entire molecule [3]. The latter approach has been more more fully 
developed [3] and is discussed here. 
 
MOLECULAR ORBITAL THEORY: HARTREE-FOCK (HF) METHODS 
Determinantal Wavefunction 
Hartree proposed that the electronic wavefunction can be separated into a product of functions, or 
Molecular Orbitals (MO), that depend on only one electron.  
𝜓 𝒓1, 𝒓2 …𝒓𝑛 = 𝜙1 𝒓1 𝜙2 𝒓2 … 𝜙𝑛 𝒓𝑛                                                                                                       2.7  
For the Pauli principle to be satisfied the total electronic wavefunction must be antisymmetric [2, 
4]. Thus, the sign of the wavefunction must change with the interchange of any two electron 
coordinates. Antisymmetric wavefunctions are built using the Slater determinant, which gives the 
sum of all possible permutations of electron pairs: 




𝜙1 𝑒1     𝜙2 𝑒1    …    𝜙𝑛 𝑒1 
𝜙1 𝑒2     𝜙2 𝑒2    …    𝜙𝑛 𝑒2 
𝜙1 𝑒𝑛      𝜙2 𝑒𝑛     …    𝜙𝑛 𝑒𝑛  




  is the normalisation factor, ei denotes electrons and the MOs, 𝜙𝑖 , are spinorbitals 













The energy of the molecule is written as the expectation value of the one and two electron 
operators from Equation (2.6) in the MO basis: 
𝐸 = ∫ 𝜓 𝒓1 , 𝒓2 …𝒓𝑛 
∗Ĥ𝜓 𝒓1 , 𝒓2 …𝒓𝑛 𝑑𝜏                                                                                                                  
     =  𝜓 Ĥ 𝜓    











                                                              (2.9)  
 𝑱𝑖 𝜙𝑗   2  =   𝜙𝑖 1  𝒈12 𝜙𝑖 1   𝜙𝑗   2                
 𝑲𝑖 𝜙𝑗   2  =   𝜙𝑖 1  𝒈12 𝜙𝑗  1   𝜙𝑖   2                
The total energy can be written as: 











                                                                                                     (2.10) 
In Equation (2.10) the one electron integral hi describes the kinetic and potential energy of the 
electron moving in the field of the bare nuclei. The two-electron integral Jij is the Coulomb 
integral representing the classical repulsion between two electrons, and Kij is the exchange 
integral. 
 
Many of the systems considered in molecular modelling are in their ground states [5]. These 
molecules are said to have closed shell configurations where the valence shell is completely 
filled. Thus, MOs are doubly occupied, with one electron spin up and the other spin down. In 
such a system each spatial orbital is restricted to two electrons and the total energy can be 
written: 


























Finding the Optimum Wavefunction: Hartree-Fock Equations 
The optimum determinantal wavefunction, ψ, can be found using the variational principal. The 
theorem states that if an arbitrary wavefunction is used to calculate the energy, the value 
calculated is never less than the true energy [2, 6]. Thus, the best ‘trial’ wavefunction, 𝜙𝑖 , can be 
generated by minimising the molecular energy as a function of the MOs. Variation of the MOs 
must be done under the constraint that the MOs remain orthonormal [1]. Carrying out the 
constrained optimisation using the method of Lagrange multipliers, it can be shown that the 
optimum MOs must satisfy the Hartree-Fock (HF) equations: 
𝑭𝒊𝜙𝑖 =  𝑖𝜙𝑖                                                                                                                                                              (2.12) 
𝑭𝒊𝜙𝑖 = 𝒉𝑖 +   2𝑱𝑗 − 𝑲𝑗  ,
𝑛/2
𝑗
                                                                                                                                (2.13) 
where εi is the MO energy and F is the Fock operator. The MOs are termed canonical MOs and 
they are obtained by choosing a unitary transformation which makes the matrix of ε diagonal (i.e. 
εij=0 and εii=εi) [2]. Since the Fock operator depends on the occupied MOs of all the electrons, 
iterative methods must be used for determining the Fock orbitals. This procedure is known as a 
self-consistent field (SCF) calculation.  
 
There are two important points regarding the results of HF SCF calculations. Firstly the canonical 
MOs are not unique since a unitary transformation applied to the occupied MOs does not change 
the total wavefunction [2]. One set of optimised MOs can be used to generate other sets, such as 
localised MOs, through linear combinations. The second note is that the repulsion between an 
electron and all other electrons is calculated using a single Slater determinant [2, 5, 7]. Thus, the 
repulsion is not exact and the HF method is also referred to as a Mean Field approximation. 
Nevertheless HF methods often give geometries and relative energies for equilibrium structures 
that are in good agreement with experiments [2]. 
 
The Basis Set Approximation 
In solving the HF equations it is practical to express the unknown MOs in terms of a set of 












𝜙𝑖 =  𝑐𝛼𝑖𝜒𝛼
𝑀
𝛼
                                                                                                                                                        (2.14) 
where α annotates the M spinorbitals. As the number of basis functions increase, the accuracy of 
the MOs improves until the HF limit is reached [2, 5]. Exponential functions 𝜒 ∝ 𝑒 −𝛼𝑟  located 
on the nucleus are well suited for electronic structure calculations, and are known to be exact 
solutions for the hydrogen atom [2]. However, they are computationally expensive. Gaussian 
functions 𝜒 ∝ 𝑒 −𝛼𝑟
2  are more efficient for calculating two-electron integrals because a product 
of two Gaussians located at two different postions can be written as a single Gaussian [2].  
 
Roothaan-Hall Equations 




=  𝑖  𝑐𝛼𝑖𝜒𝛼
𝑀
𝛼
                                                                                                                                 (2.15) 
where Fi is the Fock operator. When Equation (2.15) is multiplied on both sides by a specific 
basis function and integrated the Roothaan-Hall equations are obtained: 
 𝑐𝛼𝑖  𝜒𝛽  𝑭𝒊 𝜒𝛼 
𝑀
𝛼
=  𝑖  𝑐𝛼𝑖
𝑀
𝛼




=  𝑖  𝑐𝛼𝑖
𝑀
𝛼
𝑆𝑖𝑗                                                                                                                                    2.17  
Since there are M basis functions, there will be M such equations which can be collected in 
matrix notation. 
𝑭𝑪 = 𝑺𝑪𝜺                                                                                                                                                                 (2.18) 
F is the Fock matrix for which each element contains the one electron integrals, and a sum of the 












𝑭𝛼𝛽 =  𝜒𝛼  𝒉 𝜒𝛽  +   𝜒𝛼  𝑱𝑗 − 𝑲𝑗  𝜒𝛽  
𝑜𝑐𝑐 .  𝑀𝑂
𝑗
                                                                                            
         =  𝜒𝛼  𝒉 𝜒𝛽  +   𝐷𝛼𝛽   𝜒𝛼𝜒𝛾  𝒈 𝜒𝛽𝜒𝛿  −  𝜒𝛼𝜒𝛾  𝒈 𝜒𝛿𝜒𝛽   
𝐴𝑂𝐴𝑂
𝛾
                                                     (2.19) 
               𝐷𝛼𝛽 =  𝑐𝛾𝑗 𝑐𝛿𝑗
𝑜𝑐𝑐 .  𝑀𝑂
𝑗
 
S is the matrix of overlap integrals. C is a M x M matrix of the cαi coeffients. Each column of C is 
an expansion of 𝜙𝑖  in the terms of the atomic orbitals χα. ε is the M x M matrix of orbital 
energies. 
 
The matrix notation is advantageous because a simple algorithm can be used for solving Equation 
(2.18) [1, 2, 5]. An initial guess is made for the coefficients and used to generate the Fock matrix 
which is then diagonalised to generate a new set of coefficients. These coefficients are in turn 
used to generate a new Fock matrix and the process repeated until the coefficients used to 
generate the Fock matrix are equal to the coefficients generated from the diagonalisation.  
 
RESTRICTED AND UNRESTRICTED HARTREE-FOCK 
The closed shell system described above represents a special case of Restricted Hartree-Fock 
(RHF), which uses combinations of singly and doubly occupied molecular orbitals. RHF makes 
the restriction that for doubly occupied molecular orbitals each spatial orbital should have two 
electrons, one spin up and the other spin down [2, 5]. Alternatively, if different spatial orbital are 
allowed for the two electrons in an orbital the trial function is known as an Unrestricted Hartree-
Fock (UHF) wavefunction. The UHF treatment is an extension of the Roothaan-Hall equations 
and two sets of trial wavefunctions are optimised using the Pople-Nesbet calculations [8], one for 
spin up electrons and one for spin down electrons. 
 
SEMI-EMPIRICAL METHODS 
Full solution of the HF equations where all the necessary integrals are calculated from a given 
basis set are known as ab initio HF methods. Computational cost can be minimised by reducing 












two approximations [2]. In the first approximation only the valence electrons are treated 
explicitly using a minimum number of basis functions required for the electrons of a neutral 
atom. The second approximation is known as the Zero Differential Overlap and neglects the 
overlap between pairs of different orbitals which depend on the same electron coordinates. Some 
or all of the neglected integrals are modelled using parameters estimated from spectroscopic or 
physical data [2, 3]. Semi-empirical methods include Neglect of Diatomic Differential Overlap 
Approximation (NDDO), Intermediate Neglect of Differential Overlap Approximation (INDO) 
and Complete Neglect of Differential Overlap Approximation (CNDO). These methods are used 
when the systems are large and too expensive to model using ab initio methods. In this 
dissertation QM methods were used to obtain a reference data set for parameterisation of a MM 
force field (described later in Chapter 5). This was done for model compounds that were 
sufficiently small for treatment with post Hartree-Fock ab initio methods.  
 
ELECTRON-CORRELATION: POST HARTREE-FOCK METHODS 
HF is a Mean Field theory that assumes that electrons move in an average potential of the other 
electrons. The instantaneous position of an electron is not influenced by the presence of a 
neighbouring electron and so electron correlation is not accounted for [5]. The correlation energy 
is defined as the difference between the HF energy and the exact energy. Post HF methods 
improve on the SCF method described above by adding electron correlation. These methods 
include configuration interaction (CI), coupled cluster (CC) and Møller–Plesset perturbation 
(MP2, MP3 etc.) theory methods. 
 
DENSITY FUNCTIONAL THEORY 
Density functional theory (DFT) utilises the Hohenberg-Kohn theorem [9] which states that the 
potential of a ground state system is a functional of its electron density:  
𝐸𝑒𝑙𝑒𝑐 = 𝐸 𝜌 𝒓                                                                                                                                                        (2.20) 
Kohn and Sham [10] proposed that the functional take the form 












EKE(ρ) is the kinetic energy, EC(ρ) is the electron-nuclear interaction term, EH(ρ) is the electron-
electron Coulombic energy, and  EXC(ρ) contains the exchange and correlation terms. These 
terms are functions of the electron density. The approximate density is constructed from a set of 
one-electron orbitals: 




                                                                                                                                               (2.22) 
Since the electron density obeys the variational theorem the orbitals constructing the electron 
density can be obtained by optimising Equation (2.21) with respect to the density in a self 
consistent manner. All the ground state properties can then be calculated from the electron 
density.  
 
One advantage of DFT is that the energy of the molecule includes the electron correlation, 
although there is no way of deriving this term and its dependence on ρ(r) has to be approximated 
[5]. The primary advantage though, is that unlike the electronic wavefunction which is dependent 
on 3n variables (the x, y and z coordinates of each of the n electron), the total electron density is 
dependent on three spatial coordinates [11]. This is because the electron density is dependent on 
the integral of the orbitals squared, which is independent of the number of electrons [2]. As a 
result DFT calculations are much more computationally efficient than the wavefunction 
approach. 
 
APPLICATIONS OF MOLECULAR ORBITAL THEORY 
Once the molecular wavefunction or electron density has been solved the electronic charge 
distribution can be explored, which has important implications on reactivity [5]. Furthermore, 
using the Born-Oppenheimer approximation the potential energy surfaces of molecules can be 
created by determining the electrostatic energy of a molecule while varying the positions of the 
nuclei. A time evolution of the system can be generated by perturbing the nuclei at finite time 
intervals according to the laws of Newtonian dynamics, where the force acting on the nuclei is 
derived from the quantum mechanical potential. However, when systems are large it is necessary 












2.2. MOLECULAR MECHANICS 
Molecular mechanics (MM) is also based on the Born-Oppenheimer approximation and models 
energy as a function of nuclear coordinates [5]. MM methods model the energy landscape using a 
force field which consists of a functional form describing the molecular potential and parameters 
used by that potential function. The potential function is based on simple models of intra- and 
intermolecular interactions. All force fields contain terms for bond stretching, angle bending, 
torsional rotation and electrostatic interactions. More sophisticated force fields will contain 
additional terms [2]. The parameters used by the potential function are normally specific to atom 
types, which identify the hybridisation and local environment of the atom.  
 
Since the electronic effects are ignored in MM this treatment of molecules is more efficient than 
QM. A result of this simplification is that the primary function of force fields is often to predict 
structural properties, although they can be specifically developed to predict desired properties [5].  
 
 
2.2.1. FORCE FIELDS 
THE POTENTIAL FUNCTION 
The current research used the CHARMM potential function [12, 13]. This function is the sum 
over the individual inter- and intra-molecular interactions and takes the form: 
𝑈(𝒓) =  𝐾𝑏 𝑏 − 𝑏0 
2 +   𝐾𝜃 𝜃 − 𝜃0 
2 +   𝐾𝜑 1 + 𝑐𝑜𝑠 𝑛𝜑 − 𝛿  
𝑑𝑖𝑕𝑒𝑑𝑟𝑎𝑙𝑠𝑎𝑛𝑔𝑙𝑒𝑠𝑏𝑜𝑛𝑑𝑠
 
            +  𝐾𝜔 𝜔 − 𝜔0 
2
𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟𝑠
 +  𝑈𝐶𝑀𝐴𝑃  𝜑, 𝜓  
𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠




            +   𝑖𝑗















                                            (2.23)















The first three terms in Equation (2.23) model the standard intermolecular interactions: bond 
stretching, angle bending and torsional rotation. These terms describe the interaction energy as a 
function of the distance from an equilibrium value which is given in the parameter set. The 
equilibrium value is annotated with a zero subscript and the respective force constants, also 
defined in the parameter set, are Kb, Kθ, Kφ. The functional forms are illustrated in Figure 2-1. 
The bonding and angle terms are modelled by Hooke’s law, while the torsional rotation is 
modelled using cosine series expansion.  
 
The CHARMM potential function contains three additional terms. An out-of-plane bending term 
is used to maintain planar geometries and stereochemistry of chiral centres. The Urey-Bradley 
function is a cross-term to account for coupling between angles and the length of adjacent bonds. 
This coupling models the observation that as an angle decreases the adjacent bonds stretch to 
reduce the interactions between the 1,3 atoms [2]. Finally CMAP is the backbone torsional 
correction term [13]. 
 
INTERMOLECULAR INTERACTIONS 
The last component of a system’s energy function is the pairwise potential for non-bonded 
interactions. This term is the addition of coulomb electrostatic and van der Waals (vdW) 
interactions, the functional forms of which are summarised in Figure 2-2. Although, these 
interactions can be affected by the presence of a third, fourth or more molecules, the many-body 
effects can be parameterised into the pairwise model [5]. In this case the model uses ‘effective’ 
pairwise potentials which are not the true interaction energy between two isolated particles. 
 
Electrostatic Interactions 
The observed electrostatic interactions between molecules arise from the unequal distribution of 
charge due to differences in electronegativity of the constituent atoms [2]. In the CHARMM 
potential the electrostatic interaction is modelled by arranging partial atomic charges on the 














Van Der Waals Interactions 
Electrostatic interactions do not account for the total non-bonded interaction and in classical 
physics the vdW forces are those which account for the deviation of a real gas from ideal gas 
behaviour. VdW interactions result from long-range attractive interactions and short-range 
exchange-repulsive forces between atom pairs [2]. The attractive interactions result from 
dispersion forces between instantaneous dipoles arising from fluctuations in the electron cloud. 
The repulsive contribution arise from short-range nuclear repulsion of partially shield nuclei. The 
nuclei become partly de-shielded at short-range since exchange forbids electrons to occupy the 
same region of inter-nuclear space. In the CHARMM potential function vdW interactions are 




𝐾𝑏 𝑏 − 𝑏0 
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FIGURE 2-1 Harmonic and cosine potential functions describing intermolecular terms present in all force fields. Un is known as the 


















Potential Truncation  
The non-bonded interactions are calculated for all atom pairs in the molecular system so that the 
summation is proportional to the square of the number of atoms in the system. Since the other 
parts of the calculation are only proportional to the number of atoms in the system, calculating 
non-bonded energies is the most time consuming part of a molecular dynamics simulation [2, 5]. 
This expense can be minimised by truncating the pair potential for the non-bonded terms. Thus, 
non-bonded interactions are only calculated from neighbour atoms lying within a specified cutoff 
distance. The assumption is that the forces are negligible at the cutoff boundary because the vdW 
and electrostatic potentials tend to zero as the distance between the atom pairs tends to infinity. 
This is appropriate for the short-ranged vdW interactions since the Lennard-Jones potential has a 
r
-6
 distance dependence. For a system with bare charges or with correlated dipoles, such as an α-




Discontinuity of the electrostatic interactions 
















































noise is to use group-based cutoffs. In these methods the distance between neutral groups of 
atoms are calculated and pairwise interactions are only calculated between the atoms of two 
groups if the groups fall within a cutoff distance. Since the electrostatic interaction between two 
neutral groups is proportional to r
-3
, the range of the interaction is reduced considerably [2, 5, 14]. 
Another way to avoid discontinuities in the potential near the cutoff value is to apply a switching 
or shifting function to the non-bonded potential [15]. In the former method the entire non-bonded 
potential energy surface is shifted so that the interaction potential is zero at the cutoff distance 
(Figure 2-3). On the other hand, switching leaves the potential unaltered until a first cutoff value. 
Between this first cutoff value and the last cutoff value the interaction potential is tapered to zero. 
Beyond the practical importance of cutoff radii, truncating the pairwise potential also eliminates 
long range order which is undesirable in a simulation of bulk solvent. 
 
Non-Bonded Neighbour Lists  
Computing all atom pair distances to evaluate whether they fall within the cutoff is still time 
consuming [5]. On the assumption that an atom’s neighbours do not change significantly over 10 




















previously identified neighbours [5]. This list stores atoms within the cutoff distance, together 
with all atoms that are slightly further away. This ensures that only the distances between the 
central atom and the atoms in its neighbour list have to be computed. The frequency of updating 
the list should be slow enough to be computationally efficient but fast enough to ensure accuracy.  
 
The Ewald Summation  
When using periodic boundary conditions (Section 2.2.4), the electrostatic interaction between a 
charge and all its periodic images can be accurately computed using the Ewald summation [16, 
17]. For a box defined as (nxL, nyL, nzL), where n is its position at a cubic lattice point and L is the 
length of the cube, the charge-charge contribution to the potential energy due to all pairs of 




   
𝑞𝑖𝑞𝑗







                                                                                                            (2.24) 
where rij is the minimum distance between charges i and j. Equation (2.24) converges slowly and 
is a conditionally convergent series (i.e. depends on the order in which its terms are considered). 
The summation was reformulated by Ewald [16] as the sum of three terms which each converge 
more rapidly than Equation (2.24): 
𝑈𝑐𝑜𝑢𝑙𝑜𝑚𝑏 = 𝑈𝑟𝑒𝑎𝑙 + 𝑈𝑓𝑜𝑢𝑟𝑖𝑒𝑟 + 𝑈𝑠𝑒𝑙𝑓                                                                                                  (2.25) 
In the real space summation, Ureal, each charge is considered to be surrounded by a neutralising 
charge distribution of equal magnitude but of opposite sign. The interactions of a set of 
distributions added to cancel the initial neutralising Gaussians are calculated in reciprocal space, 
Ufourier. Finally a self-term, Uself, cancels the interaction of each of the introduced artificial 
counter-charges with itself.  
 
PARAMETERISATION 
With a potential energy function in hand, an appropriate parameter set is required. Parameters are 
chosen to best reproduce a data set which describes a system’s properties of interest. Since force 












geometries and relative conformational energies (vibrational frequencies are also common) [2, 5]. 
Ideally the data set is obtained from experimental values, but when this information is not 
available, the results of QM calculations are used. For large systems, such as that considered in 
this work, it is not practical to calculate the reference data for the whole system. Therefore, the 
system is divided into suitable fragments. Parameters are then optimised using model compounds 
representative of these fragments. 
 
Parameters for the model compounds are coupled and parameterisation demands an iterative 
procedure. Intramolecular interactions, vibrational profile and intermolecular interactions are 
optimised in turn and the cycle repeated until satisfactory agreement with the reference data set is 
obtained for each stage of the cycle [5]. Within each stage there are two methods for obtaining 
the parameters for the required terms in the potential function. The first method is by trial and 
error, in which parameters are gradually refined to get a better fit to data. The second method 
expresses an error as the sum of squares of differences betw en observed and calculated values 
for the set of properties, and the error is then minimised in an iterative procedure. When 
modelling a set of compounds not included in the existing force field, new parameters must be 
added. The initial parameters can be estimated from analogous compounds already present and 




For small molecules, partial charges can be calculated to exactly reproduce experimental electric 
moments if the geometry is known. Some force fields assign partial charges by fitting solvent-
solute interactions to QM calculated energies. A third option is to fit the partial charges to the 
electrostatic potential of the model compound [18]. The electrostatic potential is defined as the 
force acting on a unit positive charge placed at a point, and can be determined from the molecular 
wavefunction [5]. A grid of points outside the vdW radius of atoms constituting the molecule can 
be generated and the potential at each point calculated. Partial charges can then be fitted to 
reproduce the electrostatic potential at the grid points. In the CHELPG [19] method utilised in the 
current work this is achieved using the method of Lagrange multipliers with the condition that the 













The energy landscape described by the force field can be explored by optimising the energy as a 
function of the nuclear coordinates. The resultant stationary points are where the first derivative 
is zero. Important stationary points are the energy minima where the second derivatives are 
positive. There are three classes of minimisation algorithms which can be used to find the local 
minimum. 
 
Steepest Descent Methods 
Steepest descent (SD) methods calculate the gradient vector, which points in the direction of 
greatest energy increase, and the energy is lowered by stepping in the opposite direction. If the 
energy increases along this line search, an approximate minimum is determined and a new 
gradient is calculated. Subsequent line searches must be perpendicular to each other which results 
in the path oscillating around the minimum path. Furthermore as the minimum is approached the 
rate of convergence slows [2, 5]. This method is often used to quickly relax the starting 
coordinates or if more advanced algorithms fail. 
 
Conjugate Gradient Methods 
Conjugate gradient (CG) methods are similar to the SD methods except they perform each search 
along a line which is constructed so that it is conjugate to the previous search direction. During 
minimisation this results in a path which oscillates around the minimum path to a lesser extent 
than SD methods [2, 5]. 
 
Newton-Raphson Methods 
Newton-Raphson (NR) methods use first and second derivatives to find the minimum of a 
potential function. The advantage of the NR methods is that the convergence is second-order near 
a stationary point. However, minimisation can become unstable far from a minimum. 
Furthermore, if one of the second derivative values of the Hessian matrix is not positive definite 














2.2.3. MOLECULAR DYNAMICS 
CLASSICAL NEWTONIAN DYNAMICS 
Molecular dynamics (MD) simulates ‘real’ dynamics of a system. The simulation generates 
successive configurations of the system by integrating Newton’s laws of motion. The result is a 
trajectory, or a collection of coordinates and dynamical properties (velocities, accelerations, etc) 
in phase space that are connected in time. Thus, MD allows one to follow the structural and 
energetic properties of a system over time and the analysis of representative structures throughout 
the trajectory can yield a variety of information. Time-dependent properties can be calculated as 
correlation coefficients, and thermodynamic relationships are calculated from ensemble averages. 







                                                                                                                                               (2.26) 
Equation (2.26) describes the motion of a particle of mass mi in one dimension xi experiencing a 
force Fxi. The forces acting on each particle are calculated from the differential of the system’s 
force field potential. Solving this second order differential equation for every particle in the 
system, we can calculate the next configuration at any future time from an initial configuration. 
This deterministic method is continued to obtain the dynamic behaviour of the system.  
 
INTEGRATING THE EQUATION OF MOTION 
When solving Newton’s second law of motion for a system, the force acting on each particle will 
change as the particles move. This many-body problem cannot be solved analytically and the 
equations of motion embodied in Equation (2.26) are integrated using a finite difference method 
[5]. The integration is broken down into many small time intervals dt. The forces acting on each 
particle is calculated at a time t as a function of the coordinates. The accelerations of the particles 
are then determined from the forces, and used to calculate the positions and velocities at a time t 













There are many algorithms for integrating equations of motion using finite difference methods. 
These algorithms assume that the positions and dynamic variables can be approximated as Taylor 
series expansion [2, 5]: 









𝑑𝑡4𝑐 𝑡 ⋯                                                     (2.27) 






𝑑𝑡3𝑐 𝑡 ⋯                                                                             (2.28) 
𝑎 𝑡 + 𝑑𝑡 = 𝑟 𝑡 + 𝑑𝑡𝑏 𝑡 +
1
2
𝑑𝑡2𝑐 𝑡 ⋯                                                                                                      (2.29) 
where v is the velocity and a is the acceleration. CHARMM uses the Verlet [20], Leap-frog [21] 
and Velocity Verlet [22] algorithms to numerically solve Netwton’s equations of motions for all 
atoms of the system. 
 
 
2.2.4. SIMULATION CONDITIONS 
SOLVATION 
CHARMM all-atom force fields, such as that used in this dissertation, were designed for 
simulation with explicit waters [12, 13]. Water models can be broken into three types: simple 
interaction site water models, flexible models and polarisable water models [5]. In simple 
interaction site models each water molecule is defined by three to five interaction sites distributed 
over a rigid geometry. The interaction between molecules is described using pairwise Coulombic 
and Lennard-Jones expressions. Developed models include TIP3P [23], SPC/E [24], TIP4P [23] 
and TIP5P [25]. TIP3P has been used in this thesis since CHARMM force fields have been 
parameterised with this model [13]. The TIP3P model has three charges, one centred on the 
oxygen nucleus and two centred on the hydrogen nuclei. A single vdW interaction site is 
















The focus of this thesis is the dynamics of inhibitor enzyme complexes, and more specifically the 
active site of the enzyme. Therefore, it is not necessary to explicitly simulate the behaviour of 
solvent molecules far away from the enzyme. Boundary conditions are used to model a small 
number of particles far away from the boundary as if they were in bulk fluid.  
 
PERIODIC BOUNDARY CONDITIONS (PBC) 
In periodic boundary conditions the particles are placed inside a unit cell which is then replicated 
in all directions. The shape of the cell must be such that the central cell fills all of space by 
translation operations in three dimensions. Shapes that fulfil this criterion include the cube, the 
hexagonal prism, the truncated octahedron and the rhombic dodecahedron. The cubic cell is the 
simplest, and is illustrated using a 2D example in Figure 2-4. As can be seen, the number of 
particles within the central box is held constant by replacing any particle leaving the box with an 
image particle that enters from the opposite side. Although the cubic cell is the simplest, cells 
which have a more spherical geometry, such as the truncated octahedron and rhombic 
dodecahedron, will require fewer particles and are more appropriate for the simulations of 
spherical molecules. Thus, the cube and truncated octahedron have been used most widely [5]. 
Calculation of the potential is performed using the minimum image convention, in which the 
interactions of an atom are restricted to only the nearest image of the other atoms. The size of the 
unit cell is an important consideration for the simulation of non-bonded interactions. The box 
should be large enough so that the solute does not interact with itself and that no water molecules 
interact with the solute twice. In order to achieve this, the non-bonded cutoff (discussed in section 
2.2.1) should be no greater than half the length of the shortest side [5].  
 
STOCHASTIC BOUNDARY CONDITIONS 
When dealing with macromolecules, solvation in a sufficiently large unit cell for PBC requires a 
large number of water molecules to be included in the simulation. In stochastic boundary 
methods the solute of interest is solvated in a thin film of explicit water molecules, and the effect 
of the bulk solvent is included as average interactions. Such methods facilitate the efficient 
simulation of enzyme active sites. A sphere of explicit water molecules with radius R2 is centred 












molecules are then divided into three regions. All residues with an atom within R1, the reaction 
region, are subject to Newtonian dynamics, while all residues with an atom outside R2 are 
eliminated by keeping their atoms fixed. Atoms of residues that fall between the reaction and  
reservoir regions belong to the buffer region. The atoms here evolve in time according to an 





= 𝑭𝑖 𝑥𝑖 𝑡  − 𝑚𝑖Ω𝑖





𝑚𝑖 + 𝑹𝑖 𝑡                                                   (2.30) 
In Equation (2.30), Fi is the normal force experienced by the atoms in Newtonain dynamics, and 
Ω𝑖
2 𝑥𝑖 𝑡 − 𝑥𝑖
𝑟𝑒𝑓
  are boundary forces applied to solute atoms derived from atomic mean-square 
fluctuations. These boundary forces are gradually scaled over the buffer region so that they are 
weakest at the boundary of the free moving reaction region (< R1) and strongest near the  
 
 
FIGURE 2-4 Illustration of periodic boundary conditions. The central cell has a bold border and is translated to fill the 2D space with 
image cells. Any atom which leaves the cell (shown by the black atom) is replaced by its image from the opposite side. In 












boundary of the static reservoir region (> R2). Explicit water molecules are allowed to diffuse 
between the reaction and reservoir regions, and are acted upon by a deformable boundary 
potential which maintains the correct average distribution of water molecules and prevents water 
from escaping into the vacuum. The remaining forces in Equation (2.30) originate from Langevin 
dynamics and simulate the effect of bulk water. Ri are the forces of random collisions associated 
with energy and temperature, while  𝛾𝑖
𝑑𝑥𝑖 𝑡 
𝑑𝑡
𝑚𝑖  simulates the frictional drag and removes energy 
from the system[2, 5].  
 
ENSEMBLES 
Statistical mechanics uses ensembles to calculate macroscopic properties of a system, where an 
ensemble is a collection of microscopic replications belonging to the particular thermodynamic 
state [26]. The observed value of the property is replaced by an ensemble average: 
𝐴𝑎𝑣𝑒 =  𝐴 =  𝑑𝒑
𝑁𝑑𝒓𝑁 𝐴 𝒑𝑁 , 𝒓𝑁 𝜌 𝒑𝑁 , 𝒓𝑁                                                                                              (2.32) 
 
 
FIGURE 2-5 Illustration showing how stochastic boundary conditions are used to study the dynamics of enzyme-ligand complexes. This 












where the brackets indicate the ensemble average and ρ is the probability density of the 
ensemble. The ensemble generated by MD methods, discussed above, consists of configurations 
connected in time. From this trajectory the time average of a property can be calculated, which in 
accordance with the ergodic hypothesis is equal to the ensemble average: 
 𝐴 =  𝐴 𝑡𝑖𝑚𝑒 =
1
𝑀




This equality holds only if the MD simulation sufficiently samples the phase space (i.e. generates 
enough representative conformations of the system). Due to the formulation of molecular force 
field, MD most often samples the low energy conformations of the system and it is important to 
run simulations for long enough to be able to compare time averages to experimentally relevant 
information.  
 
A further consideration when comparing computational and experimental results is the choice of 
ensemble. The simulation ensemble is characterised by the parameters of the system held 
constant during the dynamics (Table 2-1). Conditions of constant number of particles, pressure 
and volume (NPT), or constant number of particles, volume and temperature (NVT), correlate 
most closely to experimental condition [27]. During simulations the temperature can be kept 
constant by rescaling velocities, coupling to a heat bath or using the Langevin equations of 
motion. The canonical (NVT) ensemble was used in the production simulations in this project 
and the temperature was kept constant using a method based on the Nose-Hoover thermostat, 
whereby the system is coupled to a heat bath. The free energies calculated in the canonical 












2.2.5. SIMULATION PROCEDURE 
A typical MD simulation is conducted as follows: 
 
Initial coordinates 
Initial coordinates for proteins can often be obtained from structures resolved using X-ray 
crystallography or Nuclear Magnetic Resonance. Alternatively a theoretical structure obtained 
from molecular modelling can be used. The choice of initial structure is important and it is best to 
choose a configuration close to the targeted simulation state [2]. 
 
Minimising the starting structure  
Some parts of the initial structure may contain high-energy interactions. There is a risk that in the 
course of the simulation the potential energy of these parts may be transformed into a high level 
of kinetic energy at a localised spot, known as a ‘hot spot’. It is therefore important to remove 
high-energy interactions by performing an energy minimisation [2]. 
 
Assignment of initial velocities 
Initial velocities are assigned to all atoms to reach the desired temperature. Assignment is often 
made according to a Gaussian distribution of velocities.  
 
Heating and equilibration dynamics 
The purpose of the heating and equilibration dynamics is to enable the crystal structure to evolve 
to reach equilibrium. The kinetic energy of the all the atoms is gradually increased by scaling or 
TABLE 2-1   Constant variables in different ensembles, and corresponding equilibrium states. 





















x (PV) has maximum Grand canonical 
 
N: Number of particles; P: Pressure; V: Volume; T: Temperature; E: Energy; μ: Chemical potential; A: Helmholtz 












reassigning their velocities at regular intervals until the system reaches room temperature. 
Equilibration is continued until a set of properties become stable. These properties include the 
thermodynamic properties of energy, temperature and pressure. The root mean squared deviation 
(RMSD) is a structural property that is a useful metric for equilibration. RMSD of a system of N 




  𝒓𝑖 𝑡 − 𝒓𝑖 0  




For a solid, the RMSD should oscillate about a mean value when at equilibrium [2, 5]. 
 
Production dynamics 
The equilibrated structure is used as the starting point and the time evolution of the system 
corresponding to the desired ensemble is simulated. The length of the simulation is dependent on 
the measurements to be made and required phase space sampling. 
 
 
2.2.6. STRUCTURAL ANALYSIS 
MD simulations of inhibitor-enzyme and substrate-enzyme complexes aim to describe the 
structure and stability of the molecular systems. The hydrogen bonding and hydrophobic 
interactions play an important role in binding of these complexes [28].  
 
Hydrogen bonding is an interaction of the type D-H····A, where a hydrogen is shared between  
donor and acceptor atoms. The D-H bond length is consistent with a covalent bond while the 
H····A bond length is shorter than the normal vdW contact distant. Typically the donor and 
acceptor groups are electronegative groups, and the hydrogen bond has both a covalent and 
electrostatic nature. The interaction also has a directional preference and the optimal orientation 
is linear [28]. The strength and geometry hydrogen bonds differ with the chemical properties of 
the donor and acceptor groups. Since the bonding is an electronic effect, characterisation of these 












such as the CHARMM-27 force field used here, the hydrogen bond interactions are 
parameterised into the Coulomb and Lennard-Jones potentials of the atoms, and a definition is 
required for simulation analyses. Structural properties are often used for this purpose. In the 
current work hydrogen bond analysis was done on an H····A distance criterion of 2.4Å, and an 
angle criterion of 120°.  
 
The hydrophobic effect is generally considered to be an entropic effect [5, 28]. Non-polar solutes 
are not able to form hydrogen bonds with water and in solution will disrupt the hydrogen bond 
network of water. As a result waters become locally ordered around the solute in a cage-like 
structure in order to maximise hydrogen bonding with the bulk water. This local order reduces 
entropy. When non-polar solutes associate water molecules are liberated and the non-polar 
surface area is reduced thus increasing the entropy. The favourable entropy change in the solvent 
due to the association of the non-polar solutes is dominant over the unfavourable enthalpic and 
entropic contributions in the solute. The association of non-polar residues due to the hydrophobic 
effect are known as hydrophobic interactions. Since the CHARMM force field models atoms 
explicitly there is no energy term for hydrophobic interactions. In classical molecular dynamics 
the hydrophobic effect is simulated using parameterised non-bonded terms. These electrostatic 
and vdW terms give rise to favourable interactions between polar moieties and favourable 
interactions between non-polar moieties. A suitable definition for identifying favourable 
hydrophobic interactions is required. One metric that can be used is the solvent exposed surface 
area of the non-polar residues. Alternatively, an interaction can be evaluated as hydrophobic in 
nature if the distance between two non-polar residues approaches their vdW contact distance and 
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FREE ENERGY AND CONFORMATIONAL ANALYSIS 
TECHNIQUES 
3.1. FREE ENERGY CALCULATIONS 
Free energy is an entropic property and is defined as the total amount of energy in a system that 
can be converted to do work [1]. A change in a system is spontaneous if the resulting change in 
free energy is negative. Therefore evaluating the free energy can give valuable information on the 
conformational preferences of molecules and favourable binding of host-guest complexes. 
 
The Helmholtz free energy, corresponding to the canonical ensemble, can be calculated exactly 
from an ensemble using Equation (3.1): 
𝐴 = 𝑘𝑏𝑇𝑙𝑛   𝑑𝒑
𝑁𝑑𝒓𝑁𝑒
+ℋ 𝒑𝑁 ,𝒓𝑁 
𝑘𝐵𝑇 𝜌 𝒑𝑁 , 𝒓𝑁                                                                                               (3.1) 
Higher energy configurations play an important role in calculating the free energy [2]. However, 
MD simulations are formulated to sample the low energy conformations of a system and will not 
adequately sample important high energy regions. Therefore, using a MD-generated ensemble to 
calculate the free energy of the system will result in poorly converged and inaccurate results. On 
the other hand, free energy differences can be readily calculated. They are a useful tool in 














3.1.1. THERMODYNAMIC CYCLE FOR THE BINDING OF HOST-GUEST 
COMPLEXES 
 
Since free energy is a state function, a closed thermodynamic cycle can be derived for association 
of two different molecules S1 and S2 with a macromolecule X (Figure 3-1). There is no 
requirement that the free energy change must take place over a physical pathway. Therefore, by 
‘mutating’ ligand S1 to ligand S2 both in solution and at the active site of an enzyme, the relative 
free energy of association, ∆∆Gass, can be calculated without having to simulate both the ligand 
binding as well as de-solvation of the ligands and the binding site [4]: 
ΔΔ𝐺𝑎𝑠𝑠 = Δ𝐺1 − Δ𝐺3 = Δ𝐺2 − Δ𝐺4                                                                                                                      (3.2) 
In Equation (3.2), ∆G1 and ∆G3 are the absolute free energies of association of X with S1 and S2 
respectively, and cannot be calculated with good accuracy ∆G2 and ∆G4 are computationally 
feasible and are used to calculate relative free energy of association. The above scheme provides 
an efficient pathway for applying ‘computational alchemy’ to investigate the specific 
contributions to ligand binding. A functional group of the ligand or a protein amino acid can be 
mutated and the resulting change in free energy evaluated. A negative free energy change 
indicates a more favourable binding of the product system and the opposite is true for a positive 
free energy change. 
 
 
FIGURE 3-1 Closed thermodynamic cycle. ∆G1 and ∆G3 are the free energies of association of macromolecule X with S1 and S2 












3.1.2. METHODS FOR CALCULATING RELATIVE FREE ENERGY OF 
ASSOCIATION  
There are three methods with which to calculate the free energy difference of two states: Free 
Energy Perturbation (FEP), Slow Growth (SG) and Thermodynamic Integration (TI) [2, 5-7]. 
 
FREE ENERGY PERTURBATION 
The relationship between the Helmholtz free energy and the partition function Q is given in 
Equation (3.3): 
Δ𝐴 = 𝐴𝑌 − 𝐴𝑋 = −𝑘𝐵𝑇𝑙𝑛
𝑄𝑌
𝑄𝑋
                                                                                                                               (3.3)  
Zwanzig showed that the free energy difference can be obtained using an ensemble average over 
the representative configurations of the initial state of the system [8]: 
Δ𝐴 = −𝑘𝐵𝑇𝑙𝑛  𝑒
− ℋ𝑌−ℋ𝑋  
𝑘𝐵𝑇  
𝑋
                                                                                                                                 (3.4) 
where ℋ𝑋  and ℋ𝑌 are the Hamiltonians for the initial state X and the final state Y respectively. 
To calculate the free energy difference a series of configurations for X is generated. The 
ensemble average is then calculated using the energy calculated for each configuration of X using 
the potential parameters of Y [2]. 
 
If X and Y do not overlap in phase space the phase space of Y will not be adequately sampled 
when simulating X. Such a scenario arises when  ℋ𝑌 − ℋ𝑋 ≫ 𝑘𝐵𝑇 and the calculated relative 
free energy difference will be inaccurate [2]. This problem can be overcome using intermediate 
states defined by a parameter λ, which couples the initial and final states. The Hamiltonian of the 
intermediate state is then defined by a proportion of the initial state and proportion of the final 
state: 












To perform an FEP calculation a number of intermediate states, λi, are specified moving from 0 
(corresponding to X) and 1 (corresponding to Y). For each intermediate state the system is 
equilibrated using the force field parameters appropriate to λi. A production stage dynamics is 
simulated and the difference in free energy calculated as: 
∆𝐴 𝜆𝑖 → 𝜆𝑖+1 = −𝑘𝐵𝑇𝑙𝑛  𝑒
− ℋ𝑖+1−ℋ𝑖 
𝑘𝐵𝑇                                                                                                             (3.6) 
The total free energy is then the sum of the free energy changes.  
 
Similarly, the free energy difference ∆𝐴 𝜆𝑖 → 𝜆𝑖−1  can be calculated. In the double-wide 
sampling technique free energy differences are calculated in both directions from 𝜆𝑖 . This is more 
efficient since twice as many free energy differences are obtained from a single simulation [2]. 
 
SLOW GROWTH 
In the slow growth method the energy function is changed continuously over the simulation by 
incrementing/decrementing λ. The free energy dif erence is then given by: 
∆𝐴 =   ℋ𝑖+1 − ℋ𝑖 
𝑖=𝑁𝑠𝑡𝑒𝑝 ;𝜆=1
𝑖=1; 𝜆=0
                                                                                                                                (3.7) 
The assumptions are that if the increments are small enough the system will remain at 
equilibrium, and furthermore that the ensemble average can be approximated by a single data 
collection point. In practice a large number of windows are required (50 000-100 000) and the 
method should be applied with caution as the implicit assumptions detailed above have not yet 
been proven [5]. 
 
THERMODYNAMIC INTEGRATION 


















                                                                                                                                                 (3.8) 
and by substituting 
𝐴 𝜆 = −𝑘𝐵𝑇𝑙𝑛𝑄 𝜆                                                                                                                                                 (3.9) 
Equation (3.10) can be derived: 
Δ𝐴 =   







                                                                                                                              (3.10) 
where λ is a coupling parameter such that λ = 0 corresponds to the initial state and λ = 1 
corresponds to the final state. TI approximates the integral in Equation (3.10). A discrete number 
of λi values are chosen and a series of simulations corresponding to those points is performed. 
The ensemble average with respect to λ is calculated. The integral is approximated by numerical 
methods such as the trapezoidal integration method for which Equation (3.10) becomes: 
∆𝐴 ≈    















                                                            (3.11) 
 
Although TI makes use of intermediates defined in terms of a coupling parameter, λi, unlike FEP, 
TI is not a windowing procedure. In FEP the formulation of the free energy difference is 
composed of exact terms and the λ-spacing is dependent on sufficient phase space sampling. 
Intermediate λ points are interpolated using double-wide sampling [5]. The free energy 
calculation using TI, on the other hand, requires the analytical integration of Equation (3.10) and 
the λ spacing is limited by the need for sufficient discrete points to approximate the integral 
accurately. Therefore, with infinite sampling both formulae are equivalent, however the 
















SINGLE AND DUAL-TOPOLOGY SIMULATIONS 
The formulations introduced above are implemented using either the single-topology [9] or dual-
topology [10] methods. The two methods will give different results for the free energy difference, 
but the double free energy difference will be the same [2, 5, 6]. 
 
In single-topology methods every atom in the initial state has a counterpart in the final state [11, 
12]. This is illustrated in Figure 3-2A, which considers the transformation of ethane to methanol. 
Since the number of atoms in the initial and final states is different, dummy atoms (D) are 
introduced for atoms which exist in one state and have no counterpart in the other. The dummy 
atoms have no non-bonded energy terms, but they are connected to the rest of the system through 
bonded interactions. The energy of the Hamiltonian for the system becomes: 
ℋ 𝒓, 𝜆 = ℋ0 𝒓 +  1 − 𝜆 
𝑁ℋ𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡  𝒓 +  𝜆 
𝑁ℋ𝑝𝑟𝑜𝑑𝑢𝑐𝑡  𝒓                                                                 (3.12) 
Where ℋ0 is the part of the potential energy that does not change, ℋ𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡  contains the energy 
terms unique to the initial state, and ℋ𝑝𝑟𝑜𝑑𝑢𝑐𝑡  contains the energy terms unique to the final state. 
 
In the dual-topology method the parts which are not the same in the initial and final state are 
defined simultaneously. In the hybrid shown in Figure 3-2B both the hydroxyl and C2 methyl 
fragments are bonded to C1. The Hamiltonian for the initial and final states therefore involves 
different coordinates: 
ℋ 𝒓, 𝒓𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡 , 𝒓𝑝𝑟𝑜𝑑𝑢𝑐𝑡 , 𝜆 
= ℋ0 𝒓 +  1 − 𝜆 
𝑁ℋ𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡  𝒓, 𝒓𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡  +  𝜆 
𝑁ℋ𝑝𝑟𝑜𝑑𝑢𝑐𝑡  𝒓, 𝒓𝑝𝑟𝑜𝑑𝑢𝑐𝑡                3.13  
Atoms for which only the charge changes in going from reactant to product are said to have a co-
located charge. During the perturbation the electrostatic interactions of the ‘colo’ atom are treated 
as perturbation interactions, and the atom is otherwise treated as an environmental atom [12]. 
Therefore, the electrostatic interactions for which the ‘colo’ atom is assigned the reactant charge 












product charge are included in HP. Reactant and product atoms do not see each other in that no 
non-bonded interactions are computed between the two groups. This thesis employs the TSM 
module in CHARMM which utilises the dual-topology methodology.  
 
TREATMENT OF BONDED INTERACTIONS 
In the dual-topology method, if the bonded interactions for the parts of the system undergoing 
transformation are scaled, certain bonds and angles are broken/formed and the end state 
corresponds to an ideal gas atom end state [11]. In the example given in Figure 3-2B the initial 
state will consist of the ethane molecule and ideal gas atoms of O and H, while the final state will 
consist of the methanol molecule and ideal gas atoms of C2 and 3  H. Difficulties are 
encountered in breaking or making bonds since there will not be adequate sampling in 
simulations of finite length [11, 13].  
 
The problems can be avoided by using a hybrid potential energy function that does not scale the 
bond and angle terms. This will obviously apply only when the transformations does not involve 
 
 
FIGURE 3-2 (A) The hybrid ethane/methanol solute used in the single-topology simulations (B) The  ethane/methanol hybrid used in the 














covalent bond association or dissociation. The end state for the free energy simulations will then 
correspond to ideal gas molecules in which the molecular fragment remains bonded to the rest of 
the system while all the other interactions of the fragment are scaled to zero. In the example 
given in Figure 3-2 the initial state will consist of the ethane and methanol molecules, however, 
environmental atoms will only interact with the ethane molecule at the initial state and only the 
methanol molecule at the final state. It has been shown that the artifacts of the simulation arising 
from not scaling the bonded terms do not affect the double free energy difference [11, 13].  
 
However, such a treatment of the bonded interactions is not appropriate for this thesis. 
Transformation along the inhibitor series in the direction 1a-1d (Figure 1-7 in Chapter 1) 
involves addition of a methylene group to the alkyl linker. If the bond and angle interactions for 
the reactant linker and product linker are treated in full, the linker of the hybrid molecule will 
assume a conformation which is a compromise between the shorter and longer linker length. 
Therefore, as λ goes from 0 to 1, the linker will not extend and differences in the interactions of 
the plumbagin moiety due to extension of the linker will not be simulated for the initial and final 
states. An alternative strategy is to scale the bonded terms but to limit the value of λ to a value at 
which a bond or angle is considered broken. Boresch and Karplus have suggested that the limits 
of 0.01 and 0.99 are appropriate for typical values for force constants of bonded terms [11, 13]. 
 
EXAMPLE: RELATIVE FREE ENERGY OF SOLVATION FOR ETHANE AND 
METHANOL 
The difference in free energy of solvation between ethane and methanol is calculated below to 
illustrate the protocol for free energy calculations:  
 
First, the starting and end topologies for the simulation were chosen. The TSM module in 
CHARMM was used with the dual-topology method. As discussed both the methyl and hydroxyl 
fragments will exist simultaneously in the hybrid (Figure 3-2B).  The chemical transformation at 
hand allowed for the internal bond and angle parameters of the hybrid to be neglected as 













The CHARMM General Force Field (CGENFF) [14] was used to model the ethane and methanol 
molecules in solution. The starting conformations of the hybrid’s methyl and hydroxyl fragments 
were generated using the internal coordinates present in the CGENFF topology file. These are 
minimum energy conformations in vacuum for each of the fragments in relation to the C1 methyl 
group.  
 
The atoms were divided into atom groups in order to calculate the classical Hamiltonian for the 
hybrid: 
ℋ 𝒓, 𝒓𝑒𝑡𝑕𝑎𝑛𝑒 , 𝒓𝑚𝑒𝑡 𝑕𝑎𝑛𝑜𝑙 , 𝜆 
= ℋ0 𝒓 +  1 − 𝜆 
𝑁ℋ𝑒𝑡𝑕𝑎𝑛𝑒  𝒓, 𝒓𝑒𝑡𝑕𝑎𝑛𝑒  +  𝜆 
𝑁ℋ𝑚𝑒𝑡 𝑕𝑎𝑛𝑜𝑙  𝒓, 𝒓𝑚𝑒𝑡 𝑕𝑎𝑛𝑜𝑙                 (3.14) 
The atoms of the C2 methyl group were designated as reactant atoms and the atoms from the 
hydroxyl fragment were designated as product atoms. The C1 atom is a ‘colo’ atom with a 
reactant charge of 0.27 and a product charge of 0.04. The remaining hybrid and solvent atoms 
were treated as environmental atoms.  
 
The coupling parameter, λ, was assigned values of 0, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 
0.95 and 1. Non linear λ scaling was used to modify the reactant and product Hamiltonians. In 
this case, the derivatives due to the product atoms are zero at λ = 0 and the hydroxyl atoms were 
deleted so that only ethane molecules interacted with the solvent. Likewise, the ethane atoms 
were deleted at λ = 1. The co-located charge on C1 was changed to 0.04 as λ was perturbed from 
0 to1. 
 
For each λ value the system was equilibrated for 100ps using stochastic boundary conditions. The 
equilibrated structures were then used for a further 100ps production. The free energy files 
written out during the production were post-processed using TI. The transformation in vacuum 
gave ΔA = 4.20kcal/mol, while the transformation in water gave ΔA = 3.27kcal/mol giving a 
ΔΔG of 7.47kcal. The negative ΔΔA correctly indicates that the solvation of the polar methanol 
is more favourable, and corresponds to the experimental value for difference in free energy of 












atoms were designated as reactant atoms, the C2 methyl atoms were designated as product atoms, 
and the charge on C1 was perturbed from 0.04 to 0.27. For the reverse direction ΔΔA = 




The primary sources of error in free energy calculations are the sampling of phase space and the 
accuracy of the Hamiltonian [2, 3, 5-7].  
 
The sampling issue refers to the adequate coverage of phase space to give reliable results. There 
is no set protocol to ensure sufficient sampling of all the relevant conformations. For proteins a 
X-ray structure for the macromolecule is chosen for which it is assumed that a simulation of 10s 
to 100s of ps on this structure would retain its essential structure and any mutation would involve 
a small enough structural change that it occurs in a practical timeframe [3]. Convergence can be 
evaluated for simulations of different length, transformations in both directions and calculations 
using different methods (FEP, TI or SG) [3, 5].  
 
The parameters and functional form of the force field, as well as the implementation of the 
molecular mechanical model must also accurately represent the system. Inaccuracies in force 
fields mean that conformations from longer simulations may drift from the crystal structure and 




















3.2. CONFORMATIONAL ANALYSIS 
3.2.1. SIMULATED ANNEALING 
The inhibitor series investigated here contains a pseudo-disaccharide in the form of the 1-phenyl- 
2-acetamido-α-D-glycopyranoside fragment. Conformation analysis of disacharides must account 
for the large number of possible combinations of rotational states for the exocyclic functional 
groups. In such a system with many degrees of freedom, there are multiple minima which prevent 
simple energy minimisation calculations from surmounting local barriers. However, starting the 
minimisation at each of the possible combinations of side groups for a particular φ, ψ point on the 
conformational energy map is computationally expensive [17].  
 
Simulated annealing can be used to efficiently solve the multivariate optimisation problem [17, 
18]. This method is equivalent to crystal melting and refreezing into a configurational minimum. 
At high temperatures the system is able to pass over any energy barriers separating local minima 
barriers. As the temperature falls, the lower energy states become more probable in accordance 
with the Boltzmann distribution. At absolute zero the system should occupy the lowest energy 
state, or global minimum (to ensure the solution is in fact the global minimum, the system would 
have to come to thermal equilibrium at an infinite number of temperature steps). It has been 
shown that the application of simulated annealing to the conformational analysis of disaccharides 
yields the same results as the computationally expensive static molecular mechanics techniques 
mentioned above [17].  
 
 
3.2.2. CLUSTER ANALYSIS 
A molecular dynamics trajectory contains a set of atomic coordinates which are dependent 
variables. Multivariate analysis can be used to reduce the dimensionality of the data and group 












explore the conformational space of the inhibitor series of interest. A non-hierarchical clustering 
algorithm, ART-2’ [15, 16], was used in CHARMM. 
 
A trajectory is created using MD and the conformation, j, of each frame is described as a vector 
of N parameters: 
𝑥𝑗 =  𝑥1𝑗 , … , 𝑥𝑁𝑗                                                                                                                                                      (3.15) 
The conformations are then clustered according to a cutoff radius in an initial learning phase and 
subsequent refining phases. 
 
The learning phase is initialised by assigning the first vector, 𝑥𝑗 , as the cluster centre of cluster α, 
𝑐𝛼 . The Euclidean distance between the cluster centre (𝑐𝛼 ) and the next conformation k is 
evaluated: 
𝑑𝑖𝑘 =   𝑥𝑘 − 𝑐𝛼 
𝑇 𝑥𝑘 − 𝑐𝛼  
1
2                                                                                                                             (3.16) 
If the distance is within a specified threshold distance conformation k is assigned to cluster α and 






                                                                                                                                         (3.17) 
If the distance falls outside the specified threshold distance, conformation k is assigned as the 
cluster centre for cluster β. This process is repeated until all conformations have been analysed, 
and the cluster centres are recalculated as each new member is added. In the refining phase the 
cluster centres are only updated until all conformations have been read in and assigned. The 
choice of the cutoff radius is important since if too big a radius is chosen there will be overlap 
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MSHB ACTIVE SITE AND NATURAL SUBSTRATE 
BINDING 
4.1 INTRODUCTION 
The structure of 1-D-myo-inosityl-2-acetamido-2-deoxy-α-D-glucopyranoside Deacetylase 
(GlcNAc-Ins Deacetyalse, MshB), and the catalytic mechanism for deactylation of GlcNAc-Ins 
(Figure 4-1A) have been presented in detail in Chapter 1. As discussed, the binding mode of the 
natural substrate and the proposed mechanism (Figure 4-1C) remain uncertain. The binding mode 
of the 2-acetamido glucose unit has been modeled by Baker and coworkers [1] (Figure 4-1B) 
based on the orientation a β-octylglucoside (BOG) molecule, which was adventitiously co-
crystallised in the putative active site of their MshB crystal structure. In addition docking studies 
have also been used to explore the binding of GlcNAc-Ins [2, 3], but there is no report in the 
literature of the dynamic behaviour of MshB. Therefore, in view of the primary aim of this 
project, to describe the binding of the inhibitor series 1a-d (Figure 1-7, Chapter 1), it is important 
to delineate the MshB active site and model the binding of GlcNAc-Ins. 
 
There are two crystal structures available for MshB, pdb structures 1Q74 [4] and 1Q7T [1]. 
Crystal structure 1Q7T, resolved at 1.9Å by Baker et al., contains two independent protein 
molecules (Chain A and Chain B). Chain A contains the co-crysallised BOG molecule used to 
model the binding of GlcNAc, and is also the most complete structure. Whereas 1Q74 is missing 
coordinates for residues 1-2, 100-103, 164-169 and 300-303, 1Q7T Chain A is only missing 


















FIGURE 4-1 (A) Natural substrate with carbon atoms numbered. (B) Proposed binding of the GlcNAc moiety of the natural substrate 
modeled on the binding of BOG. The model shows coordination of the acetyl oxygen to the zinc ion . The binding of the 
glucose moiety is by mediated hydrogen bonds between the oxygens at C-3 and C-4, and Arg68. Asp95 forms hydrogen 
bonds with the oxygens at C-4 and C-6. Figure taken from Baker et al. [1]. (C) Proposed mechanism for the catalytic 














4.2.1 PROTEIN PREPARATION 
STRUCTURE REFINEMENT 
The missing residues of MshB, 165-170, form a loop between helices 6 and 7 and is situated on 
the surface of the protein some 25Å away from the recognised zinc binding pocket (Figure 1-5, 
Chapter 1). The loop was repaired by building the missing residues in Maestro [6] and 
minimising the loop using the OPLS 2005 force field while keeping all resolved atoms fixed.  
The zinc binding site was modeled on the 1Q74 holoenzyme crystal structure. To achieve this, 
1Q74 chain A was aligned to 1Q7T chain A and the coordinates of the zinc, together with its 
bound waters, were added to 1Q7T. The His13 side chain was then flipped so that N
δ1
 




Protons were added to the repaired structure to simulate the protein at a pH of 7.  The protein was 
analysed using pKaTool [7], which yielded a titration curve and a calculated pKa for each 
residue. When the pKa of an ionisable group is well below the current pH, the amino acid will 
most likely exist in its deprotonated state. Similarly amino acids with a pKa greater than the 
current pH are likely to be protonated. The calculated pKa’s for the 23 Asp and 14 Glu residues 
of the protein were well below 7 suggesting deprotonated states at that pH value. The calculated 
pKa’s for the 2 Lys, 20 Arg and 8 Tyr residues suggested the normal protonated states. For the 
His residues which had pKa values close to 7, protonation states were assigned by examining the 
titration curves from the pKaTool calculations and looking at the environment of each residue. 
This analysis indicated that His27, His60 and His144 should be protonated. However, the above 
protonation scheme gave a total charge of -12, and it was decided for more accurate simulation of 
the electrostatic interactions in CHARMM to protonate His170, His149, His131 and His36 which 











4.2.2 BINDING POCKET DETECTION 
Potential MshB binding sites for inhibitor series 1a-1d were located using CASTp [8]. CASTp is 
a webserver that uses alpha shape and discrete flow theory to locate and measures protein pockets 
and pocket mouth openings, as well as cavities. A single cavity was detected and a molecular 
surface of the atoms lining the binding site was calculated in PyMol [9] using van der Waals 
(vdW) radii from the CHARMM27 force field [10, 11]. The electrostatic surface potential was 
calculated using Adaptive Poisson-Boltzmann Solver (APBS) [12] which solves the Poisson-





Since the binding mode of the natural substrate is unknown, the previously modeled binding 
orientation of the 2-acetamido glucose unit (Figure 4-1B) was used as a template for de novo 
docking. Docking was carried out using Glide [13-16]. A receptor grid (inner-box size 10Å x 
10Å x 10Å; outer-box size 35Å x 35Å x 35Å) was generated for MshB. The zinc-coordinated 
waters were excluded to allow sampling of possible coordination geometries for the acetyl 
oxygen and zinc. The grid was centered inside the cavity identified by CASTp and a metal site 
was specified at the Zn
2+
 ion. The grid was then used in standard precision docking calculations, 
in which the MshB protein structure was held rigid during the docking. Poses had to satisfy a 
favourable metal interaction between Zn
2+
 and the GlcNAc-Ins amide oxygen. The docking poses 
were evaluated by the empirical scoring function GlideScore, and poses were regarded as 
duplicates if they had an RMS of less than 1.5Å and a maximum atom displacement of less than 
2.3Å. The highest ranked pose with a binding mode resembling that modeled by Baker et al. was 














4.2.4 MOLECULAR DYNAMICS SIMULATIONS 
 
The CHARMM33b2 program [17, 18] was used for all macromolecular simulations. The 
empirical energy function employed by CHARMM is shown below:  
𝑈(𝒓) =  𝐾𝑏 𝑏 − 𝑏0 
2 +   𝐾𝜃 𝜃 − 𝜃0 
2 +   𝐾𝜑 1 + 𝑐𝑜𝑠 𝑛𝜑 − 𝛿  
𝑑𝑖𝑕𝑒𝑑𝑟𝑎𝑙𝑠𝑎𝑛𝑔𝑙𝑒𝑠𝑏𝑜𝑛𝑑𝑠
 
            +  𝐾𝜔 𝜔 − 𝜔0 
2
𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟𝑠
 +  𝑈𝐶𝑀𝐴𝑃  𝜑, 𝜓  
𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠




            +   𝑖𝑗















                                                     (4.1)
𝑛𝑜𝑛 −𝑏𝑜𝑛𝑑𝑒𝑑  𝑝𝑎𝑖𝑟𝑠
 
The bonded and non-bonded terms were calculated using the CHARMM27 force field parameters 
[10, 11] for protein atoms and CSFF[19] force field parameters for GlcNAc-Ins atoms. The zinc 
ion was modeled using recent experimentally consistent parameters developed by Naidoo et al. 
[20]. A 14Å cut-off radius was applied in the generation of the pairlist, and a 12Å cut-off radius 
was applied on an atom by atom basis for non-bonded energy calculations. The long range 
interactions were truncated using a shifting function. 
 
For stochastic boundary dynamics, a spherical boundary force was applied to the surface of a 
29Å water sphere to maintain a consistent water density of 1.0g/dm
3
. A 6Å thick outer shell was 
selected as the buffer region, wherein langevin friction coefficients of 62.0 ps
-1
 and 200 ps
-1
 were 
applied to water oxygen atoms and protein heavy atoms respectively. Stochastic boundary forces 
were applied to protein heavy atoms in the buffer region, and multiplied by a screening function 













 for sidechain heavy 
atoms. All hydrogen bond lengths were kept fixed using the SHAKE algorithm [21]. The 














The coordinates of the protein and ligand atoms were initialised in CHARMM. The waters of 
crystallisation, including one of the zinc bound waters, were read in and their hydrogens added 
using the hbuild utility. The complex was then carefully minimised in vacuum to reduce any 
steric clashes: (1) The protein atoms were fixed and the ligand, waters of crystallisation and 
protein hydrogens were minimised for 100 steps; (2) The protein backbone was fixed and a 
harmonic force of 30N was applied to the side chains and then progressively removed over three 
cycles of 200 minimisation steps; (3) A harmonic force of  30N was applied to the backbone 
atoms and then progressively removed over three cycles of 200 minimisation steps; (4) The 
whole system was minimised without any constraints for 200 steps. All minimisations were 
performed using the Adopted Basis Newton-Raphson (ABNR) method with a step size of 0.2. 
After the initial minimisation, the complex was hydrated in a 29Å sphere of TIP3P [22] water 
molecules to a density of 1.21g/dm
3
. The hydrated complex was minimised in four steps: (1) 
Protein heavy atoms were fixed while the ligand, water and protein hydrogen atoms were 
minimised for 1000 steps; (2) The protein backbone atoms were fixed while the rest of the system 
was minimised for 1000 steps; (3) Finally the whole system was minimised without any 
constraints for 1000 steps. 
 
HEATING 
After minimization the solvated system was slowly heated from 138.15K to 298.15K. A 1ps 
verlet dynamics was run, with velocities initially assigned to a Gaussian distribution at 138.15K. 
The velocities were then scaled every 0.1ps, using a single factor for all atoms, until the system 
reached 148.15K. Thereafter, fifteen cycles of 5ps langevin dynamics was run using the leapfrog 
verlet algorithm. During each cycle the velocities were scaled to increase the system’s 
temperature by 10K in the first 2ps, and equilibration was run at that temperature for the next 3ps. 
A stepsize of 1fs was used and the non-bonded lists were updated every 20 steps. After heating to 
298.15K, the system was re-solvated to a density of 1.23g/dm
3
 in order to fill any vacuum spaces 














Atom velocities were reassigned at 298.15K according to a Gaussian distribution, and, after a 1ps 
verlet dynamics, the system was subjected to 5ns of langevin dynamics using the leapfrog verlet 
integrator.  A step size of 1fs was used and the non-bonded lists were updated every 20 steps. 
Coordinates were saved every 0.2ps.  
 
 
4.3 PHYSIOCHEMICAL PROPERTIES OF THE MSHB 
BINDING SITE 
4.3.1 GEOMETRY OF THE BINDING SITE 
MshB is a monomer consisting of 303 amino acids that are folded into a single α/β domain 
(Section 1.2). The loops and excursions originating from the C-terminal ends of the β strands 
form the putative active site as well as a three-stranded antiparallel β-sheet subdomain. Analysis 
of MshB using CASTp revealed a large binding site (Figure 4-2). The site has been divided into 
geometric regions in relation to the putative active site, which is positioned near the center. The 
active site cavity, annotated Region A, is composed of the BOG-binding residues as well as the 
zinc binding pocket. On one side the active site narrows at Gly97 and Asp95 to form Region B, a 
tunnel between the loop connecting helices α2 and α4, and the loop linking β-strand β2 and helix 
α4. On the opposite side of the active site, Tyr142 lies across the pocket partially closing off the 
active site from a large, buried cavity. This cavity, coloured purple, sits between the mixed β-
sheet of the α/β domain and the anti-parallel β-sheet comprising the subdomain. In the crystal 
structure resolved by James and coworkers [4] Tyr142 faces away from the binding pocket 













4.3.2 CHEMICAL PROPERTIES OF THE BINDING SITE 
The residues forming the MshB binding site are summarised in Table 4-1. The amino acids are 
grouped according to the region in which they are found and the polarity of their side chain. 
Region A, the active site cavity, is composed primarily of residues with polar side chains. As 
previously discussed in Section 1.2, Asp16, His13 and His147 form the zinc binding pocket, 
while Arg68, Asp15, Asp95 and His144 are proposed to mediate binding of the glucose ring in 
the natural substrate [1]. With this proposed glucose binding mode the α-linked myo-inositol 
group at C-1 of the natural substrate would sit at the mouth of the binding pocket and the amide 
group would point towards Region C. Glu47 Gln247, Ser260 and Asn261 are all positioned at the 
roof of the Region A as depicted, and are potential hydrogen bonding partners for myo-inositol. 
Of the non-polar residues, Met98 helps form the mouth of the binding site on the left hand side of 
Region A, while Val248 and Leu259 are situated next to Region C. The latter are in close 
proximity to the position of the non-polar acetyl hydrogens. 
 
FIGURE 4-2 Molecular surface of the binding site detected by CASTp. The putative active site is shown in red and encloses a vdW 














TABLE 4-1   Decomposition of binding site residues according to region and property of their side chain. 







































Asp 59, 62, 102 
Arg 94, 104, 108 
Uncharged Polar 
Thr 57, 101 
Gln 103 
Ser 105 












Region B consists of almost exclusively polar residues (Table 4-1) with a large number of 
negatively charged sidechains. Region C on the other hand has many non-polar residues lining its 
surface. Figure 4-3C shows the contribution of non-polar residues to the molecular surface of the 
MshB binding site. 
 
The electrostatic potential calculated for MshB using APBS [12] was plotted onto the molecular 
surfaces of the protein and binding site (Figure 4-3). Region A and Region B are mostly 
electronegative with some areas of positive electronegativity due to contributions from Zn
2+
, 
Arg68 and His144. Region C shows a much more neutral electronegativity profile, which is 
indicative of its non-polar, hydrophobic nature. 
 
 
4.4 NATURAL SUBSTRATE BINDING 
GlcNAc-Ins was docked into the active site of MshB, and the solvated system was subjected to 
5ns molecular dynamics (MD) simulation. The resulting trajectory was analysed to investigate 
the binding of the natural substrate. The root-mean-squared-deviation (RMSD) of amino acids 
within 8Å of GlcNAc-Ins was plotted against time, once the translational and rotational 
movement of the macromolecule had been removed (Figure 4-4). The plot shows the active site 
settles quickly and can be seen to be stable from 2ns onwards.  
 
The final nanosecond of the trajectory was used to analyse the enzyme-substrate binding 
interactions. The interaction energy (IE) was calculated for residues of increasing distance from 
the inhibitor in order to identify residues which are important for binding. The non-bonded 
interactions were then calculated for these residues every 0.2ns, and the average values are 
reported in Table 4-2. Hydrogen bonding was detected using an in house code based on a 
distance cutoff of 3.5Å and an angle cutoff of 120
o
. Since the CHARMM force field models 
atoms explicitly, there is no energy term for hydrophobic interactions. Rather, the hydrophobic 















FIGURE 4-3  (A) Electrostatic potential mapped on to the molecular surface of MshB. Blue shows areas of positive electronegativity, 
and red shows areas of negative electronegativity. The RWB color scheme covers the range from -3 to 3kT.e-1. (B) 
Electrostatic potential mapped onto the molecular surface of the MshB binding site. (C) Molecular surface of the binding 













give rise to favourable interactions between moieties of the same polarity. Therefore, 
hydrophobic interactions were evaluated based on an inter-residue distance in conjunction with 
the vdW interaction energy. 
 
Figure 4-5 summarises the binding simulated between the natural substrate and MshB (GlcNAc-
Ins is illustrated with relevant atom labels in Figure 4-1A). The IE of binding is dominated by the 
electrostatic interaction between the acetamido oxygen and zinc ion (93.27kcal/mol). The C-2 
acetamido methyl group is in close proximity to the non-polar residue Leu259, which has an IE 
of 1.66kcal/mol with the natural substrate. Figure 4-6 shows that the distance between the center 
of mass (COM) of the Leu259 side chain and the methyl group fluctuates minimally around its 
optimal distance. This distance was calculated by moving the Leu259 away from the methyl 
group in vacuum and locating the energy minimum. Furthermore, there are no water molecules 
between the two groups, which are seen to have favourable hydrophobic interactions. 
 
Recognition of the glucose moiety is mediated by Arg68 (16.48kcal/mol) and Asp95 
(22.79kcal/mol) through hydrogen bonds. The oxygen from the C-3 hydroxyl group is a 
hydrogen bond acceptor to Arg68 N
1
, while the hydroxyl hydrogen displays hydrogen bonding 
geometry, for a significant proportion of the trajectory, with a water molecule bridging the 
proposed catalytic residue Asp15. The oxygen of the hydroxyl group at C-4 is also hydrogen 
bonded to Arg68 N
1





of Asp95 is hydrogen bonded to the hydroxyl hydrogen at C-6. Contrary to the binding model 
 











proposed by Baker et al., His144 fulfills the geometric criteria for hydrogen bonding with the C-6 
hydroxyl oxygen only sparsely over the 1ns trajectory. 
 
The myo-inositol moiety sits at the entrance of the binding pocket exposing the hydroxyls to non-
specific interactions with the bulk water. However, the oxygen of the hydroxyl group at C-2 is 
hydrogen bonded to a water molecule bridging Glu47 and the hydroxyl hydrogen displays 
hydrogen bond geometry with Ser260 for part of the trajectory. The oxygen from the hydroxyl at 
C-5 displays consistent hydrogen bonding to Asn261 over the trajectory. Contacts between the 
non-polar hydrogens of Met98 and the three axial hydrogens on one face of the D-myo-inositol 
satisfied the distance criteria for hydrophobic interactions (Figure 4-6). Gammon et al. [2] have 
reported that in a study of the substrate specificity of MshB, a benzyl group was found to be the 
most suitable analogue for D-myo-inositol. It is envisaged that the non-polar benzyl moiety forms 
hydrophobic interactions with Met98 in a similar fashion to the interactions reported here for D-
myo-inositol. This would explain the suitability of the benzyl group as a substrate analogue. 
 
 
TABLE 4-2 Decomposition of the IEs between GlcNAc-Ins and MshB residues. The sum of the reported energies are given (Total), 
along with the IEs calculated for the entire inhibitor with MshB. All energies are reported in kcal/mol. 
Residue Total  VDW  ELEC  
Zn -93.27 6.43 -99.70 
Leu259 -1.66 -0.65 -1.01 
Arg68 -16.48 0.42 -16.90 
Asp95 -22.79 3.14 -25.93 
Asp15 -3.71 -1.04 -2.67 
His144 -9.08 -0.46 -8.62 
Met98 -2.10 -3.45 1.35 
Ser260 -1.07 -0.92 -0.15 
Asn261 -4.02 -1.46 -2.57 
Total -154.18 2.00 -156.19 


















FIGURE 4-5 (A) 2D diagram showing the binding mode of the natural substrate after 5ns of MD simulation. (B) 3D illustration of the 
natural substrate binding after 5ns MD showing the zinc binding pocket and catalytic residues. The catalytic water is 
labelled and its oxygen is in a suitable position for attack on the acetylamido carbonyl. (C) Hydrogen bond network 
mediating the binding of GlcNAc-Ins. The water-bridged interaction between Glu47 and the hydroxyl oxygen at C-2 is 














4.5 PLUMBAGIN CONJUGATES AS MSHB INHIBITORS 
The current research aims to investigate the inhibition of substituted naphthoquinones in relation 
to binding strength. The series of inhibitors under investigation consists of a methyl derivative of 
plumbagin linked at the C-2 position of a phenyl thioglycoside. Since the 2-acylamido-α-D-







FIGURE 4-6 (A) Hydrophobic interactions involving Met98 and Leu259. (B) Time series for the distance between the COM of Met98 
side chain atoms and the COM of non-polar hydrogens from the face of the myo-inositol closest to Met98. (C) Time series 
for the distance between the COM of non-polar hydrogens from Leu259 and the COM of the C-2 acetamido methyl group. 













bind this moiety selectively and in a similar orientation to GlcNAc-Ins. In this orientation the 
naphthoquinone derivative and alkyl linker would be directed towards the cavity adjacent to the 
active site, which has a complementary hydrophobic character (Figure 4-3). The C-1 phenylthio 
group, like myo-inositol, would sit at the mouth of the binding pocket in close proximity to the 
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RATIONALISING THE INHIBITION OF MSHB BY A 
SERIES OF PLUMBAGIN CONJUGATES 
A series of inhibitors, constructed from plumbagin tethered via 2 to 5 methylene carbons and an 
amide linkage to phenyl-2-deoxy-2-amino-1-thio-α-D-glucopyranoside (GlcNAc-SPh, Figure 5-
1), have been shown to inhibit MshB [1]. Kinetic studies revealed the inhibition to be competitive 
and inhibition constants were calculated for 1a, 1c and 1d. Since the inhibition constant, Ki, is the 
dissociation constant of the enzyme-inhibitor complex, it is a measure of its strength: a high Ki 
indicates weak binding and a low Ki indicates strong binding. The Ki values of the plumbagin 
derivatives indicate that their binding affinity increases with the length of the spacer. This chapter 
describes the use of free energy calculations to calculate the relative binding strengths of the 
inhibitors. Molecular dynamics (MD) trajectories of the inhibitors bound to the MshB active site 





Calculated Ki (µM) 
1a 57.4% 167±15 
1b 81.6% - 
1c 81.4% 94±11 
1d 94.8% 16.8±19 
 
 
FIGURE 5-1 (A) Structure of inhibitor series with carbon atoms number. (B) Table reporting the percentage inhibition of MshB at 














The GlcNAc-SPh moiety was modelled using the CSFF force field [2]. The phenyl, alkyl linker 
and plumbagin functional groups were modelled using the CGENFF force field [3], and missing 
parameters were estimated from analogous bonds, angles and dihedrals. However, there were no 




Brooks et al. have investigated how different charge assignment schemes for small molecules in 
conjunction with the CHARMM22 force field impact the quality of computed binding affinities 
[4]. It was found that fitting partial charges to the electrostatic potential yielded the best results. 
Thus, in the current research a 5-hydroxy-2,3-dimethyl-1,4-naphthoquinone fragment was 
optimized at the MP2/6-31g(d) level of theory using Guassian03 [5]. Partial charges were then fit 
to the electrostatic potential using the CHELPG algorithm [6] (Figure 5-2). The charges of the 
quinone and hydroxyl moiety, including the ipso carbon, were estimated directly from the 
CHELPG charges and then uniformly offset such that this group of atoms had a total charge of 0. 
The remaining atoms were assigned charges according to the CGENFF force field guidelines [3]. 
Thus, aliphatic hydrogen atoms were assigned a charge of +0.09 and the aromatic C-H groups not 
adjacent to a heteroatom were assigned a charge of -0.115 and +0.115 on the C and H atoms 
respectively. To validate the charge assignment the electrostatic potential from the QM 
minimised structure was compared to electrostatic potential generated from point partial charges 
















DIHEDRALS IN THE THIOGLYCOSIDE LINKAGE 
Dihedral parameters for the thioglycoside linkage (Figure 5-4) were absent in the CGENFF and 
CHARMM27 force fields. The φ and ψ parameters were first approximated using CSFF-
consistent parameters for sulphur linked saccharides [7]. To validate the parameters a relaxed 
dihedral scan of GlcN-SPh was simulated using GuassianO3 at the HF/6-31g(d) level of theory. 
Coordinates at the stationary point determined for each (φ,ψ) combination were read into 
CHARMM and minimised. The energies from the QM and MM simulations were used to plot 
comparative adiabatic maps (Figure 5-4). Use of the CSFF-consistent parameters yielded an 
energy profile with an extra minima at φ=50. However, when Amber-consistent parameters [8] 




FIGURE 5-2 (A) Charges calculated for the 5-hydroxy-2,3-dimethyl-1,4-naphthoquinone fragment using the CHELPG algorithm and 



















FIGURE 5-3 2D contour plots for the QM (A & C) and MM (B & D) generated electrostatic potentials for 5-hydroxy-2,3-dimethyl-1,4-
naphthoquinone: (A & B) Electrostatic potential in the plane of the aromatic groups and (C&D) Electrostatic potential 

















Dihedral K n δ 
O5-C1-S1-C1 0.1095 1 0 
 
-0.6860 2 0 
 
0.7820 3 0 
C2-C1-S1-C1 -0.7257 1 0 
 
-0.1997 2 0 
 
0.3473 3 0 
H1-C1-S1-C1 0.1854 3 0 
C2/C3-C1-S-C1 -0.7257 1 0 
 
-0.1997 2 0 
 
0.3691 3 0 
C2-C1-S1-C1 -0.7257 1 0 
 
-0.1997 2 0 
 
0.3473 3 0 
 
Dihedral K n δ 
O5-C1-S1-C1 1.4200 1 -9.7 
 
1.2700 2 -27.8 
 
0.2000 3 -32.1 
C2-C1-S1-C1 0.8100 1 -22.8 
 
-0.2100 2 -83.8 
 
0.1800 3 -77.5 
 
0.4600 4 -77.5 
H1-C1-S1-C1 0.1853 3 0 
C2/C3-C1-S-C1 -0.7257 1 0 
 
-0.1997 2 0 
 
0.3691 3 0 
C2-C1-S1-C1 -0.7257 1 0 
 
-0.1997 2 0 
 
0.3473 3 0 
 
 
Figure 5-4 Parameterisation of the thioglycoside dihedrals. (A) QM adiabatic map. (B) MM adiabatic map using CSFF-consistent 
parameters. (C) MM adiabatic map using Amber parameters for θ and CSFF-consistent parameters for ψ. Contours are 




















5.1.2. STRUCTURAL STUDY OF INHIBITORS IN SOLUTION 
SIMULATED ANNEALING 
The phenyl 2-acetylamido-1-thioglycoside unit was subjected to simulated annealing analysis, 
according to the procedure described by Naidoo et al. [9]. Thus, an energy surface was generated 
in three stages: 
 
The energy landscape of the pseudo-disaccharide was divided into 361 grid points. Grid points 
were defined by each combination of the (φi,ψi) dihedral angles resulting from their rotation 
through 360˚ in intervals of 20˚.  At each (φ, ψ) combination the GlcNAc-SPh fragment was 
subjected to a three step simulated annealing procedure. First energy was supplied to the system 
in order to overcome any barriers separating local minima. This was achieved by heating the 
pseudo-disaccharide from 200K to 900K in intervals of 100K every 1ps over a period of 9ps. 
Next the molecule was cooled to 300K over 20ps, in decrements of 60K every 2ps forcing it into 
lower energy regions. These low energy regions were explored by dynamic quenching, where the 
temperature was dropped to 250K after 2ps and then to 200K after a further 2ps, before the 
system was equilibrated  at 200K for 11ps. Finally the coordinates resulting from this annealing 
process were minimised with 1000 steps of conjugated gradient minimisation, while constraining 
the glucose ring to a 
4
C1 chair and the thioglycosidic dihedrals to the (φ, ψ) combination of the 
relevant grid point.  The final combination of exocyclic dihedral angles of the glucose ring was 
used in the starting geometry for each new next grid point.  
 
Five low energy conformations identified from the results of the above calculation were refined 
by repeating the simulated annealing procedure 35 times to obtain a normal distribution of means. 
Initial conditions were different at every point since the velocities were assigned using a newly 
generated set of random numbers. For each calculation starting geometries were continually 
replaced with the lowest energy geometry obtained from the preceding runs in order to increase 
the probability of locating a global minimum at that φ, ψ point.  
 
A smoothed adiabatic map was finally obtained by evaluating six geometries at each of the 361 












conformation at that point from step 1, and five new geometries constructed by superimposing 
onto this initial conformation the five different sets of exocyclic dihedrals obtained from the 
refinement procedure.  
 
SOLUTION DYNAMICS  
Inhibitors were solvated in a 50Å
3
 water box of TIP3P [10] water molecules such that the water 
density was 1g/dm
3
. Each solute was placed in the centre of the box, and all water molecules 
closer than 2.2Å from the solute heavy atoms were deleted. The system was slowly heated from 
48K to 298K over 25ps using the leapfrog verlet integrator, and equilibrated at a constant 
pressure of 1atm for a further 250ps, using Nose-Hoover thermostat to control the temperature. A 
14Å cut-off radius was applied in the generation of the pairlist, and a 12Å cut-off radius was 
applied on an atom by atom basis for non-bonded energy calculations. The electrostatic 
interactions were treated using the Ewald summation, and the long range van der Waals (vdW) 
interactions were truncated using a shifting function. Each of the systems were then subjected to 
a further 5ns of MD using the Leapfrog Verlet integrator. The simulations were conducted under 
conditions of constant volume and temperature, and the systems were considered to be at 
equilibrium when the temperature was stable at 298K, and the kinetic energy fluctuated 
minimally around a steady value.  
 
 
5.1.3. SIMULATION OF INHIBITORS DOCKED WITH MSHB 
DOCKING 
The inhibitors were docked with the MshB crystal structure repaired in Chapter 4. Docking was 
carried out using Glide [11-14]. A receptor grid (inner-box size 10Å x 10Å x 10Å; outer-box size 
35Å x 35Å x 35Å) was generated for MshB without the zinc-coordinated waters. The grid was 
centred inside the binding cavity identified by CASTp and Asp95 O
δ2
 was specified for use in 
subsequent steps. Standard precision docking calculations were run with the MshB protein 
structure held rigid. The charges and vdW radii of atoms belonging to Tyr142, which lies across 












hydrogen was constrained to within 2.7Å of Asp95 O
δ2
. The top twenty distinct poses were 
reported, where poses were regarded as duplicates if they had an RMS of less than 0.5Å and a 
maximum atom displacement of less than 1.3Å. The docking poses were evaluated by the 
empirical scoring function GlideScore, and the highest ranked pose with a binding mode of the 
sugar resembling that modelled by Baker et. al [15] (and discussed in Chapter 4) was chosen for 
subsequent dynamics simulations. 
 
DYNAMICS 
The docked complexes were solvated, minimised, heated and then subjected to 5ns stochastic 
boundary dynamics using the same procedure described for the natural substrate in Section 4.2.4. 
 
 
5.1.4. FREE ENERGY SIMULATIONS 
The methodology of free energy calculations is given in Section 3.1. Calculation of the relative 
free energy of solvation for ethane and methanol is presented in Section 3.1.3 to aid the reader in 
understanding the calculation process using thermodynamic integration (TI).  
 
Dual-topology free energy simulations were run in the TSM module in CHARMM [16, 17]. 
Calculations were run for hybrids in both directions, from 1a to 1d and from 1d to 1a. Inhibitor 
hybrids for water free energy calculations were constructed from the most populated cluster 
centres found in the principal component analysis of the inhibitor trajectories in water, and 
hybrids for protein free energy calculations were constructed from the equilibrated enzyme-
inhibitor complexes. Inhibitor hybrids were constructed by building additional methylene atoms 
onto the structure of the initial inhibitor, so that the alkyl linkers of the reactant and product 
inhibitors existed simultaneously. To reduce errors a minimum number of atoms were mutated. 
Thus, a single methylene group was inserted/deleted at the C-2′ position of the plumbagin (Figure 
5-1). The enzyme hybrid and water hybrid systems were then partitioned into environmental 
atoms, reactant atoms (linker atoms belonging exclusively to the reactant) and product atoms 












and product atoms were ignored. Internal bond, angle and dihedral terms of the alkyl linkers were 
treated as perturbation terms, since it is important that the linker chain extends fully.  
 
Free energy perturbation (FEP) methods were initially used, but large changes in ∆A at the end-
points were observed indicating insufficient phase space sampling. This was seen to be the result 
of product/reactant atoms that were only weakly bonded to the hybrid since the bonded terms of 
the alkyl linker were scaled. This was overcome using TI and non-linear  scaling. (Dependence 
of ∆A on  for the transformation of 1d-1c using both FEP and TI is illustrated in Appendix A. 
As noted in Section 3.1.2, in FEP, intermediate  points are interpolated using double-wide 
sampling and the -spacing is dependent on sufficient phase space sampling. On the other hand 
-spacing in TI is dependent on sufficient discrete points to approximate the integral accurately). 
For each transformation, free energy data at the initial and final states and from λ= 0.01 to 0.99 
was analysed using thermodynamic integration. λ points were spaced at intervals of 0.025 except 
at the endpoints (0.01 to 0.1 and 0.9 to 0.99) where the values were spaced at intervals of 0.005. 
In the protein simulations each intermediate was equilibrated for 400ps followed by 100ps of data 
collection, and in water simulations each intermediate was equilibrated for 200ps to ensure the 
inhibitor did not approach the Langevin boundary. 
 
 
5.2. STRUCTURAL STUDY OF HYDRATED INHIBITORS 
Simulated annealing (Section 3.2.1) was used to describe the energy landscape of the pseudo-
disaccharide GlcNAc-SPh with respect to the two thioglycoside dihedrals φ (C2-C1-S1-C1) and 
ψ (C1-S1-C1-C2). The resulting adiabatic map of phenyl 2-acetamido-1- thioglycoside showed 
low energy conformations at φ=-40 (Figure 5-5). Within this valley there are two minima at ψ -
100 and 100, separated by a barrier of 2kcal/mol. For simulations of 1a, 1b, 1c and 1d in 
solution, inhibitors were initialised with φ=-40 and ψ=100, and the alkyl linker projecting linearly 
from the C-2 amido group. The inhibitors were solvated in water and subjected to 2.5ns of 












energy (φ,ψ) conformations (Figure B-1, Appendix B). The trajectories were then analysed with 
principal component analysis (PCA), using the ART-2’ algorithm [18, 19] (Section 3.2.2). The 
linker dihedrals were used as the principal component (Figure 5-6) and a cluster threshold was 
chosen to give the least cluster overlap, while at the same time not artificially separating clusters. 
The results are summarised in Table 5-1. Although there is little variation in the dihedral 
connecting the linker to the naphthoquinone, the rest of the linker shows a greater freedom. 
Figure 5-7 shows the conformations of the most populated cluster centres from each simulation. 
Interestingly, these cluster centres have their plumbagin moiety proximal to the phenylthio and/or 
linker groups. This is seen to be a result of the hydrophobic effect, in which the two hydrophobic 
moieties try to maximise their surface contact and in so doing release waters to the bulk solution 
and increase the entropy of the system. In 1a and 1b the phenyl ring interacts with the linker and 
plumbagin methyl groups, but in 1c and 1d a longer linker results in the aromatic hydrogens of 
plumbagin approaching the phenylthio group. To further investigate the conformation of each 
inhibitor in solution, 1b, 1c and 1d were built with their plumbagin moiety sitting under the 
phenylthio moiety and subjected to 5ns of molecular dynamics. Two starting conformations 




















planar plumbagin was presented to the phenylthio group. The conformations from the trajectories  
were analysed using PCA, with the distance between the centres of mass (COM) of the 
phenylthio and naphthoquinone moieties as the criteria for clustering. The clusters are 
summarised in Table 5-2. With the exception of 1b(ii), the most populated clusters are described 
by centres which have the smallest distance between their phenylthio and naphthoquinone 
groups, and typically the number of members decreases as the bond distance of the cluster centre 
increases. The conformations for the centres of the most populated clusters are presented in 
Figure 5-8. The cluster centres from the analysis of the two 1b simulations are very similar, with 
the plumbagin methyl group and the phenyl ring in close proximity. The cluster centres of 1c and 
1d show geometry indicative of favourable intramolecular hydrophobic interactions between the 
phenylthio and plumbagin aromatic groups. For each of these two inhibitors, different MD 
starting conformations resulted in two distinct relative conformations of the phenylthio and 
plumbagin groups at the cluster centres. The most populated cluster centre for 1a in the first 
PCA, and the most popular cluster centres for 1b, 1c(i), 1c(ii), 1d(i) and 1d(ii) in the second 

















TABLE 5-1   Clusters arising from inhibitor trajectories in solution, using linker dihedrals as the principal component. 
Sim Cluster #members std. dev. θ ψ χ ω ζ η 
1a 1 7076 49.90 128.8 -170.44 -35.01 - - - 
 
2 6496 53.00 124.92 171.3 -25.07 - - - 
 
3 5072 48.50 -137.39 171.36 -42.09 - - - 
 
4 5356 46.30 -128.4 -171.28 -51.27 - - - 
1b 1 9048 98.50 35.81 -155.6 -10.47 88.9 - - 
 
2 14952 96.40 44.08 117.77 -6.14 88.48 - - 
1c 1 18451 109.00 105.71 -24.01 -26.6 14.48 -75.06 - 
 
2 5549 122.00 -136.38 9.33 -26.98 -29.29 -47.94 - 
 
3 8443 84.70 -76.91 100.59 43.63 146.41 84.32 - 
1d 1 3736 62.00 22.15 111.24 155.18 52.85 160.47 -91.12 
 
2 6649 75.60 58.39 -17.58 124.25 52.84 -171.33 -88.31 
 
3 2971 91.80 42.04 124.56 -165.29 50.39 33.05 -90.99 
 
4 3299 97.00 61 -119.14 -158.41 -4.82 15.13 -89.86 
 

















TABLE 5-2 Clusters arising from PCA analysis of the inhibitor trajectories in solution. The distance between the COM of their 
phenylthio and plumbagin moieties was used as the principal component. 
Simulation Cluster # members std. dev. d 
1b(i) 1 21354 0.80 5.58 
 2 15588 0.94 8.00 
 3 13058 0.92 12.20 
1b(ii) 1 14260 0.36 6.00 
 2 13802 0.39 4.65 
 3 13197 0.39 7.15 
 4 5101 0.59 8.86 
 5 2640 0.86 11.31 
1c(i) 1 16495 0.17 3.83 
 2 13072 0.18 4.38 
 3 8590 0.22 5.06 
 4 4264 0.28 6.87 
 5 1863 0.56 7.90 
 6 5716 0.26 5.93 
1c(ii) 1 25424 0.36 4.19 
 2 10845 0.52 5.69 
 3 6953 0.57 7.88 
 4 3486 0.67 9.82 
 5 3292 0.80 12.41 
1d(i) 1 9413 0.34 4.85 
 2 24793 0.24 3.92 
 3 4838 0.44 6.34 
 4 7789 0.40 7.77 
 5 3167 0.69 9.23 
1d(ii) 1 27621 0.41 4.14 
 2 5787 0.71 6.83 
 3 5858 0.64 8.97 
 4 7668 0.63 11.20 





























5.3. ENZYME INHIBITOR COMPLEXES 
5.3.1. DOCKING AND MOLECULAR DYNAMICS 
Since a structure for 1a, 1b, 1c or 1d (Figure 5-9) co-crystallised with MshB has not been 
reported, de novo docking had to be carried out. The Sitemap [20] utility in Maestro was used to 
generate hydrophobic, hydrogen bond acceptor and hydrogen bond donor surfaces for the binding 
cavity (Figure 5-10). The natural substrate from previous docking studies is also shown. It is clear 
from Figure 5-10A that, if the binding orientation of the inhibitor glucose moieties is similar to 
that modelled for the natural substrate, the large hydrophobic cavity adjacent to the active site 
will be suitably located for binding the C-2 acylamido group. Within this cavity the carbonyl 
groups of Ser20 and Thr183, as well as the hydroxyl group of Thr183, form a favourable 
environment for hydrogen bond donating groups. The roof of the cavity is lined with a number of 
leucine groups (Leu259, Leu263, Leu265 and Leu19) which give rise to a hydrophobic region 
shown in yellow. Hydrogen bond accepting regions include the space around Lys237, Ser20 and 
His272. 
 
In order to be consistent with the orientation of the co-crystallised BOG in the 1Q7T structure
3
 
[15], docking was carried out with the constraint that the oxygen at the inhibitor C-4 position 
must be hydrogen bonded to Arg68 and Asp95. The vdW radii and charges for Tyr142 were 
scaled since it lay across the cavity, which was not observed in 1Q7T chain B or any of the 1Q74 
molecules. The docking results showed that the longer chains of 1c and 1d allowed their 
plumbagin hydroxyl group to approach within hydrogen bonding distance of the Thr183 hydroxyl 
moeity. The docking conformation of 1d (Figure 5-10B), also shows the naphthoquinone oxygen 
at C-1’ close to the Ser20 hydroxyl group, and the methyl group at C-3′ in close proximity to the 
previously identified hydrophobic region. This orientation of the naphthoquinone, in comparison 
to a conformation in which the quinone is flipped by 180˚, appears complimentary to the MshB  
                                                 
3
 The assumption made here is that MshB binds specifically to the glucose unit of the inhibitor, the same moiety 
proposed to regulate the binding mode of the natural substrate (Chapter 4). There is evidence in the literature of the 
binding of the plumbagin orthohydroxycarbonyl functional group to metal ions (For an example of coordination of 
plumbagin to Cu(II) refer to [21]). Thus, an alternative binding mode may considered in which plumbagin 
coordinates to the MshB Zn
2+
. However, there is no experimental data on the inhibitory activity of plumbagin, and 












binding pocket, and is preserved in the top ranked docked poses for 1a and 1b, even though they 
do not have long enough alkyl linkers to form hydrogen bonding with Thr183. The docking 
conformations with the best Glide score were solvated in a TIP3P water sphere, minimised and 
heated before they were subjected to 5ns stochastic boundary dynamics. In order to confirm that 
the aforementioned naphthoquinone orientation gave the best binding, the plumbagin group was 
flipped by 180˚ and these conformations were also subjected to MD simulations. IEs for all 
inhibitors were lowest for the inhibitors with the original naphthoquinone orientation. 
 
 
5.3.2. TRAJECTORY ANALYSIS 
The MD trajectories were analysed using a series of techniques. RMSD analysis was conducted 
to determine when the systems were at equilibrium. The time series for the RMSD of amino acids 
within 8Å of the inhibitors are given in Appendix C. In all systems the MshB active site is seen to 
be at equilibrium from 1ns, at which time the amino acid residues fluctuate about stable positions.  
 
 














FIGURE 5-10 (A) Surfaces produced by the Sitemap utility in Maestro. Hydrophobic surface at an isovalue of -1.5kcal/mol is shown in 
yellow, and hydrogen bond donor and acceptor sites are shown at an isovalue of -10kcal/mol in red and purple 














Analysis of inhibitor binding was conducted on the final 1ns of the 5ns trajectory. Key amino 
acids were identified by computing their average interaction energies (IEs) with the respective 
inhibitors. The residues have been grouped into amino acids forming the active site cavity (Table 
5-3) and those lining the adjacent hydrophobic cavity (Table 5-4). Table 5-5 reports the sum of 
the energies presented in Table 5-3 and Table 5-4, and also gives the IEs calculated between the 
inhibitors and all protein residues, as well as between the inhibitors and all residues in the system. 
The time series of the IEs with all residues in the system are given in Figure 5-11. The van der 
Waals (vdW) and electrostatic components of the interactions were also delineated to determine 
the nature of interactions.  
 
Hydrogen bonding was defined using an angle criterion of 120˚ and a distance criterion of 3.5Å. 
As in Chapter 4, hydrophobic interactions were assessed according to an interaction specific 
distance criterion. For each residue type a representative orientation with respect to the relevant 
inhibitor moiety was chosen from the coordinates of the MshB-1d complex after 5ns of 
equilibration. An IE scan was then conducted by moving the residue away from the inhibitor 
moiety in vacuum, and the optimal inter-residue distance was calculated to be at the energy 
minima. Contacts between non-polar inhibitor moieties and non-polar amino acids were then 
evaluated to be hydrophobic in nature if there were no waters between them, and the two groups 
































TABLE 5-3 Average IEs for amino acid residues lining the ative site. All Energies are calculated in kcal/mol and only interactions with an energy less than -1kcal/mol or greater than 1 
kcal/mol are reported. The sums of the interactions are also given (Total). 
Residue 
1a 1b 1c 1d 
Total VDW ELEC Total VDW ELEC Total VDW ELEC Total VDW ELEC 
Asp15 -7.47 -1.59 -5.88 -4.50 -0.96 -3.54 -2.64 -1.11 -1.53 -4.05 -1.26 -2.79 
Asp16 15.77 -1.48 17.25 18.84 -1.56 20.40 16.63 -1.58 18.21 18.71 -1.53 20.25 
Glu44 -0.98 -0.27 -0.71 -0.98 -0.32 -0.66 -0.99 -0.29 -0.70 -1.06 -0.33 -0.73 
Glu45 -2.54 -0.96 -1.57 -2.00 -1.05 -0.95 -2.36 -1.34 -1.02 -3.06 -1.27 -1.80 
Gly46 -2.79 -1.18 -1.61 -1.82 -0.60 -1.22 -2.33 -0.92 -1.42 -2.71 -1.00 -1.72 
Glu47 -2.92 -1.74 -1.18 -4.22 -2.25 -1.97 -3.21 -1.52 -1.69 -4.74 -2.89 -1.85 
Arg68 -16.77 0.89 -17.66 -14.65 -0.27 -14.38 -17.01 0.92 -17.93 -18.15 0.54 -18.69 
Asp95 -22.14 2.70 -24.83 -24.20 3.33 -27.53 -21.85 2.35 -24.20 -23.03 3.51 -26.54 
Met98 -0.18 -0.52 0.35 -1.25 -1.45 0.20 -1.08 -1.19 0.10 -3.61 -3.24 -0.37 
His144 -11.11 -3.15 -7.96 -7.86 -2.25 -5.61 -11.79 -2.68 -9.11 -1.94 -0.87 -1.07 
His147 5.67 -1.00 6.67 2.27 -1.35 3.62 3.17 -2.08 5.25 4.51 -1.49 6.00 
Glu213 -0.47 -0.02 -0.45 -2.41 -0.32 -2.09 -3.56 -0.46 -3.09 -1.34 -0.07 -1.27 
Gln247 -1.21 -0.95 -0.26 -1.38 -0.87 -0.51 -1.40 -0.55 -0.85 -1.17 -0.96 -0.21 
Asn261 0.04 -0.25 0.29 0.02 -0.20 0.23 -4.11 -3.09 -1.02 -0.11 -0.42 0.30 
Zn -91.55 6.54 -98.09 -97.49 5.81 -103.30 -91.63 6.36 -97.99 -98.18 6.23 -104.42 














TABLE 5-4 Average IEs for amino acid residues lining the cavity adjacent to the putative active site. All Energies are calculated in kcal/mol and only interactions with an energy less than -
1kcal/mol or greater than 1 kcal/mol are reported. The sums of the interactions are also given (Total). 
Residue 
1a 1b 1c 1d 
Total VDW ELEC Total VDW ELEC Total VDW ELEC Total VDW ELEC 
Leu19 -4.87 -4.85 -0.02 -2.03 -1.99 -0.04 -2.54 -3.05 0.51 -2.09 -3.52 1.43 
Ser20 -2.55 -0.88 -1.67 -0.50 -0.45 -0.06 -1.21 -1.81 0.60 -3.56 -3.78 0.22 
Tyr136 -0.98 -0.21 -0.77 -0.35 -0.77 0.43 -1.57 -1.65 0.08 -0.87 -1.46 0.59 
Asp137 0.32 -0.01 0.32 -4.38 -0.12 -4.26 -1.16 -0.19 -0.98 -4.80 -0.32 -4.48 
Gly140 0.39 -0.06 0.45 -3.06 0.04 -3.09 1.64 -0.47 2.11 1.30 -0.40 1.70 
Tyr142 -6.02 -4.97 -1.05 -4.30 -3.89 -0.41 -4.52 -3.85 -0.67 -3.97 -2.59 -1.38 
Thr183 -0.06 -0.07 0.00 -0.78 -0.12 -0.66 -1.05 -0.63 -0.42 -4.04 -1.38 -2.66 
Val184 -0.15 -0.04 -0.11 0.14 -0.10 0.24 -0.36 -0.39 0.04 -1.83 -1.47 -0.36 
Leu185 -1.26 -1.28 0.03 -0.60 -0.67 0.06 -3.46 -3.38 -0.07 -4.42 -4.02 -0.40 
Lys237 1.34 -0.09 1.42 -0.06 -0.01 -0.05 -1.78 -0.06 -1.72 -2.59 -0.17 -2.41 
Leu259 -1.45 -1.76 0.31 -1.16 -1.65 0.49 -0.93 -1.53 0.60 -0.52 -1.02 0.50 
Leu265 -1.04 -1.20 0.16 -1.07 -0.88 -0.19 -0.86 -0.92 0.06 -0.80 -0.78 -0.03 
Leu268 -0.44 -0.70 0.25 -0.20 -0.18 -0.02 -1.40 -1.04 -0.36 -1.44 -1.06 -0.38 
Total -16.79 -16.10 -0.69 -18.33 -10.78 -7.55 -19.20 -18.98 -0.22 -29.63 -21.97 -7.65 
 
 
TABLE 5-5 The sum of total IEs reported in Table 5-3 and Table 5-4 (Total) is compared to IEs between MshB and the inhibitors (MshB). IEs with all atoms in the system are also 
reported (All). All Energies are calculated in kcal/mol and Ki values are given in brackets. 
Residue 
1a (167 + 15μM) 1b (94 + 11μM) 1c 1d (16.8 + 1.9μM) 
Total VDW ELEC Total VDW ELEC Total VDW ELEC Total VDW ELEC 
Totals -155.43 -19.08 -136.34 -159.97 -15.10 -144.87 -163.36 -26.15 -137.21 -169.56 -26.99 -142.56 
MshB -155.74 -27.84 -127.89 -157.43 -23.43 -134 -162.95 -36.44 -126.52 -166.68 -37.07 -129.61 















Figure 5-9 gives the structures of the inhibitor series with relevant atom labels. Their binding is 
summarised in Figure 5-12 to Figure 5-18, which give a snapshot of the binding modes after 5ns 
stochastic boundary dynamics. All inhibitors displayed a glucose binding orientation resembling 
that of the natural substrate model (Chapter 4). Hydrogen bonds and metal interactions dominate 





 respectively. Hydrogen bonding is also observed between the C-6 hydroxyl 
hydrogen and Asp95 O
δ1
, and between the C-4 hydroxyl hydrogen and Asp95 O
δ2
. Together with 
the carbonyl-zinc interaction, these electrostatic interactions are the most favourable ones (Tables 
3, 4 and 5). With the above glucose orientation the phenylthio group is directed towards the 
entrance of the active site, and the C-2 acylamido side chain extends from the zinc coordinated 
carbonyl into the adjacent hydrophobic cavity.  
 
Interactions with MshB residues that play a key role in binding 1a, 1b, 1c and 1d are described in 
more detail below. For the characterisation of hydrophobic interactions, the trajectory was 
inspected to see that water molecules did not lie between the inhibitor and the respective residues. 
The inter-residue distances were also calculated and are given as time series in Figure D-1 to 




BINDING OF 1A 
The hydrogen bonding and electrostatic interactions are summarised in Figure 5-12, and the 
hydrophobic interactions are illustrated in Figure 5-14. As discussed above interaction of the 2-
acetamido glucose with MshB is dominated by hydrogen bonding and electrostatic interactions. 
However, binding is also mediated by a large number of hydrophobic interactions. The 
phenylthio and linker groups form a hydrophobic pocket with Leu259 (vdW 1.76kcal/mol, total 
1.45kcal/mol). The time series of the COM separation between the Glu47 non-polar atoms and 
the phenylthio atoms (Figure D-1, Appendix D), shows that the two methylene groups from the 












to the non-polar hydrogens at C-5 and C-6, and have favourable vdW and electrostatic 
interactions with the inhibitor (vdW 2.54kcal/mol, total 2.79kcal/mol). His144 makes an 
important contribution to the IE with strong vdW and electrostatic interactions (total 
11.11kcal/mol). However, hydrogen bond analysis showed His144 N
ε2
 fulfilled hydrogen bond 
criteria with the C-6 hydroxyl hydrogen periodically over the trajectory. 
 
The plumbagin moiety sits in a cavity adjacent to the active site with its aromatic atoms lying 
against a hydrophobic surface composed of Tyr142, Leu185, Leu265  and Leu268 (Figure 5-14). 
Tyr142 (vdW 4.97kcal/mol, total 6.02kcal/mol) and Leu19, which is located on the opposite 
face of plumbagin (vdW 4.85, total 4.87), make a significant enthalpic contribution to binding. 
Hydrogen bond analysis showed that the plumbagin hydroxyl forms temporary hydrogens bonds 
with Ser20 (total 2.55kcal/mol) and a water molecule bridging Asp16. Non-specific hydrogen 
bonding was also detected between the naphthoquinone oxygens and water along the final 1ns of 
the trajectory.  
 
 
BINDING OF 1B 
The hydrogen bonding and electrostatic interactions are summarised in Figure 5-13, and the 
hydrophobic interactions are illustrated in Figure 5-14. In 1b the phenylthio moiety forms 
favourable interactions with Met98 (vdW -1.45kcal/mol, total, -1.25kcal/mol). A time series 
shows that their relative positions fluctuate about the optimal distance calculated from energy 
scans in vacuum (Figure D-5, Appendix D). As in 1a, Glu45, Gly46 and Gly47 show favourable 
interactions with the glucose and phenylthio moieties with Gly47 providing a significant 
enthalpic contribution to binding (total -4.22kcal/mol). In addition the phenylthio group displays 
an electrostatic interaction of -2.09kcal/mol (total -2.41kcal/mol) with Glu213. 
 
The longer linker of 1b extends the plumbagin group further into the cavity than in 1a. As a 
result Leu265 and Tyr142 (vdW 3.89kcal/mol, total 4.30kcal/mol), together with Leu19 (vdW 
1.99kcal/mol, total 2.03kcal/mol), now surround the alkyl linker. While Tyr142 is shown in 
close proximity to the methyl group at C-3, analysis of the MD trajectory revealed that over the 












plumbagin aromatic atoms (Figure D-7 and Figure D-8, Appendix D). Although not illustrated in 
the 2D representation of the last time step (Figure 5-15), hydrogen bonding analysis showed that 
the plumbagin hydroxyl oxygen is hydrogen bonded to His147 N
δ1
. However, the favourable 
hydrogen bonding is offset by a clash in partial charges to give a net positive IE. Gly140 makes 
an important enthalpic contribution to binding (total 3.06kcal/mol). Hydrogen bonding analysis 
showed that the C-8 hydroxyl hydrogen alternatively forms and breaks hydrogen bonds with 
Gly140 O, and a water bridging the protein. The hydroxyl group at C-8 also forms favourable 
electrostatic interactions with Asp137 (ELEC 4.26kcal/mol, total 4.28kcal/mol). The 
naphthoquinone oxygens at C-1 and C-4 form hydrogen bonds with the surrounding water 

















FIGURE 5-12 (A)A 2D snapshot summarising the binding of 1a with MshB. Hydrophobic atoms are shown in green, polar amino 
acids are shown in cyan and charged amino acids are shown in red. The size of the residue indicates its relative position. 
(B) A 3D snapshot showing residues which have important electrostatic and hydrogen bond interactions with the 
















FIGURE 5-13 (A)A 2D snapshot summarising the binding of 1b with MshB. Hydrophobic atoms are shown in green, polar amino 
acids are shown in cyan and charged amino acids are shown in red. The size of the residue indicates its relative position. 
(B) A 3D snapshot showing residues which have important electrostatic and hydrogen bond interactions with the 


















FIGURE 5-14 3D snapshot showing the hydrophobic interactions of (A)1a and (B) 1b. Carbon atoms of the hydrophobic residues are 














BINDING OF 1C 
The hydrogen bonding and electrostatic interactions are summarised in Figure 5-15, and the 
hydrophobic interactions are illustrated in Figure 5-16. The interactions mediating 1c binding are 
very similar to the MshB-1b complex. Met98 (vdW -1.19kcal/mol, total -1.08kcal/mol), His144 
(total 11.79kcal/mol), Glu45 (total -2.36kcal/mol), Gly46 (total 2.33kcal/mol), Glu47 (vdW 
1.34kcal/mol, total 3.21kcal/mol) and Glu213 (total 3.56kcal/mol) are important in binding 
the phenyl thioglycoside moiety (Figure 5-16). Asn261 shows favourable vdW interactions with 
the inhibitor (vdW 3.09kcal/mol, total 4.11kcal/mol), and together with Glu47, makes a 
hydrophobic pocket with the phenylthio group of the inhibitor. The distance between 1c and the 
non-polar atoms of Glu47 and Asn261 fluctuate around a steady value close to the optimal inter-
residue distance in vacuum (Figure D-9, Appendix D). Hydrogen bond analysis showed unstable 
hydrogen bonding between His144 and the C-6 hydroxyl oxygen (total 11.79kcal/mol) over the 
final 1ns of the trajectory. 
 
Leu19 (vdW -3.05kcal/mol, total -2.54 kcal/mol), Leu259, Leu263, Leu265 and Leu268 form a 
hydrophobic pocket with the linker and plumbagin methyl groups. Extension of plumbagin into 
the cavity allows for favourable hydrophobic interactions with Tyr142 (vdW 3.85kcal/mol, total 
4.52kcal/mol) and Leu185 (vdW -3.38kcal/mol, total 3.46kcal/mol). On the opposite 
plumbagin face, Tyr136 forms hydrophobic contacts with the aromatic atoms (vdW 
1.65kcal/mol, 1.57kcal/mol) and the positively charged Lys237 residue has an electrostatic IE 
of -1.72kcal/mol (total 1.78kcal/mol). The hydroxyl oxygen at C-8 shows hydrogen bond 
geometry with His147 H
δ1
, but again clashes in the atomic charges result in a net positive IE. 
Analysis of the MD trajectory showed that the C-8 hydroxyl hydrogen is initially hydrogen 
bonded to a water molecule bridging Thr183 and Asp137. However, the hydrogen bond breaks 
and is replaced by an intramolecular hydrogen bond to the quinone oxygen at C-1′. The break of 


















FIGURE 5-15 (A) A 2D snapshot summarising the binding of 1c with MshB. Hydrophobic atoms are shown in green, polar amino 
acids are shown in cyan and charged amino acids are shown in red. The size of the residue indicates its relative position. 
(B) A 3D snapshot showing residues which have important electrostatic and hydrogen bond interactions with the 

















FIGURE 5-16  3D snapshots showing  the hydrophobic interactions of 1c. Carbon atoms of the hydrophobic residues are shown in 















BINDING OF 1D 
The hydrogen bonding and electrostatic interactions are summarised in Figure 5-17, and the 
hydrophobic interactions are illustrated in Figure 5-18. Met98 lies directly below the phenylthio 
group and has a strong IE with 1d (vdW 3.61kcal/mol). The tripeptide Glu45 (3.06kcal/mol), 
Glu46 (2.71kcal/mol) and Glu47 (vdW 2.89kcal/mol, total 4.74kcal/mol) make significant 
enthalpic contributions to binding in a manner similar to that already described for 1a, 1b and 1c.  
 
Leu265, Leu268 and Leu269 make hydrophobic contacts with the C-3 methyl and/or linker 
groups. Tyr142 (vdW 2.59kcal/mol, total 3.97kcal/mol) and Leu185 (vdW 4.02kcal/mol, 
total 4.42kcal/mol) form a complementary surface for the plumbagin and linker moieties. At the 
opposite plumbagin face, Tyr136 forms hydrophobic contacts with the aromatic atoms of the 
plumbagin moiety. Ser20 makes favourable vdW and electrostatic interactions with the 
plumbagin (total 3.56kcal/mol), and the positively charged Lys237 interacts electrostatically 
with 1b (ELEC 2.41kcal/mol, total 2.59kcal/mol). Finally, the 5-membered alkyl linker 
extends the plumbagin sufficiently so that it forms a stable hydrogen bond with a water molecule 
bridging Thr183 and Asp 137. An IE of 4.67kcal/mol was computed for the interaction between 















FIGURE 5-17 (A) A 2D snapshot summarising the binding of 1b with MshB. Hydrophobic atoms are shown in green, polar amino acids 
are shown in cyan and charged amino acids are shown in red. The size of the residue indicates its relative position. (B) A 
3D snapshot showing residues which have important electrostatic and hydrogen bond interactions with the inhibitor 

















FIGURE 5-18 3D snapshots showing the hydrophobic interactions of 1d. Carbon atoms of the hydrophobic residues are shown in yellow 













COMPARISON OF BINDING 
It may be expected that the phenyl thioglycoside moiety displays similar IEs along the inhibitor 
series, since an identical moiety is binding specifically to MshB in each instance. However, the 
IEs between the phenyl thioglycoside and MshB (Table 5-6) showed a 9.9kcal/mol difference for 
1b and 1c. This difference can be explained in part by binding variation with Met98 and His144 
described above. The binding of Met98 is particularly flexible. 1d displays the most favourable 
interactions with Me98, which is positioned directly under the phenylthio group of the inhibitor, 
thereby optimising hydrophobic surface contact with the aromatic ring. The IE is weaker in the 
1b and 1c complexes, both of which have Met98 orientated against the edge of the phenylthio 
group. In the MshB-1a complex, Met98 is far from the phenylthio group and the IE is negligible. 
In the improved interaction geometry of the 1d complex, the methionine occupies the space 
inhabited by His144 in 1a, 1c and 1d (Figure D-18, Appendix D). As a result His144 is located 
further from the phenylthio group with a concomitant weakened interaction when compared to 
the shorter linked inhibitors. Hydrogen bonding analysis detected hydrogen bonds between the C-
6 hydroxyl oxygen and His144 for 1a and 1c, which have the strongest IEs with the histidine. 
Further significant variation in IE is observed in the glucose binding residues Asn261 (Figure D-
18, Appendix D), Arg68 and Asp95. Zn
2+
 displays improved interaction with 1c and 1d because 
of electrostatic interactions with the plumbagin (7.86kcal/mol for 1c and 2.57kcal/mol for 1d). 
The variation in phenyl thioglycoside binding suggests that the active site formed by the loops 
between secondary structures (Section 1.2.1) is flexible.  
 
The variation in phenyl thioglycoside binding makes it difficult to establish whether increasing 
the alkyl spacer improves binding of the linker and plumbagin. The unnormalised IE of the linker 
with MshB increases with the number of methylene groups. The plumbagin moiety on the other 
hand does not follow the experimentally observed trend. 1d and 1b have the lowest IEs followed 
by 1a and then 1b (Table 5-6). The longer linker does improve the IE with certain amino acids. 
Closer proximity of plumbagin to Leu185 improves the IE of their hydrophobic interaction. 
Extension of the naphthoquinone group also improves electrostatic interactions with Thr183 and 
Lys237. A comparison of the distance and energy time series of 1a-1d with these residues can be 
found in Figure D-19 (Appendix D). In 1d the longer linker also facilitates hydrogen bonding 












TABLE 5-6 Average IEs for inhibitor moieties with MshB atoms. Energies are all reported in kcal/mol. The sum of the IEs are given (Total) along with the IE calculated for MshB with the 
entire inhibitor (MshB). 
Inhibitor Moeity 
1a 1b 1c 1d 
Total VDW Elec Total VDW Elec Total VDW Elec Total VDW Elec 
 Amidoglucose -122.13 -2.75 -119.37 -113.49 -2.04 -111.45 -118.82 -2.46 -116.36 -115.36 -1.45 -113.91 
Phenylthio  -8.03 -5.90 -2.13 -9.27 -6.08 -3.19 -13.89 -8.31 -5.59 -9.24 -7.83 -1.42 
Linker -4.92 -3.00 -1.92 -7.60 -3.73 -3.86 -9.15 -5.78 -3.37 -9.47 -6.50 -2.97 
Plumbagin -20.66 -16.19 -4.47 -27.07 -11.58 -15.49 -21.09 -19.89 -1.20 -32.61 -21.30 -11.31 
Total -155.74 -27.84 -127.89 -157.43 -23.43 -134.00 -162.95 -36.44 -126.52 -166.68 -37.07 -129.61 




TABLE 5-7 Average IEs for inhibitor moieties with all atoms. Energies are all reported in kcal/mol. The sum of the IEs are given (Total) along with the IE calculated for inhibitors with all 
the remaining atoms in the system (All). 
Inhibitor Moeity 
1a 1b 1c 1d 
Total VDW Elec Total VDW Elec Total VDW Elec Total VDW Elec 
Amidoglucose -123.92 -0.72 -123.21 -120.28 -0.36 -119.92 -127.31 -1.96 -125.35 -122.54 -0.65 -121.89 
Phenylthio  -16.34 -13.25 -3.09 -16.39 -13.67 -2.72 -16.31 -14.63 -1.67 -17.08 -14.77 -2.31 
Linker -5.93 -4.40 -1.53 -8.30 -5.72 -2.58 -10.21 -8.13 -2.08 -12.95 -10.38 -2.57 
Plumbagin -35.04 -20.16 -14.88 -47.20 -19.64 -27.55 -32.83 -22.57 -10.26 -48.70 -22.77 -25.94 
Total -181.23 -38.52 -142.71 -192.16 -39.40 -152.77 -186.65 -47.29 -139.35 -201.27 -48.57 -152.70 












interaction is unstable in 1c and does not exist in 1a and 1b. However, the above interactions do 
not underlie a trend in the IE. Hydrophobic interactions with Tyr142, Leu19 and Leu259 are 
weakened in the longer chained inhibitors. Electrostatic interactions with Asp137 are most 
favourable for 1b and 1d which have an outward facing C-8 hydroxyl hydrogen and less 
favourable for 1a and 1c. Furthermore, the hydrogen bond formed by the C-8 hydroxyl group 
with the MshB-bridging water molecule does not furnish the 1d with a significantly improved IE. 
The plumbagin hydroxyl group of 1a has an IE of -7.64kcal/mol with the surrounding waters, 
which is comparable to 1b (-6.00kcal/mol) and 1c (12.72kcal/mol).  
 
Therefore, on a purely enthalpic interpretation, the binding modelled here does not reproduce the 
experimental trend of increasing binding strength with increasing alkyl linker. Inhibitor IEs do 
not arise from specific interactions enabled by a longer linker. Rather, they arise from additive 
IEs of the respective moieties, for which only the linker region displays a trend. However, 
intramolecular interaction and the entropic contributions will play an important role in the 
binding, especially considering the hydrophobic nature of the linker and naphthoquinone 
moieties. Therefore, free energy calculations are required to determine which inhibitors bind 
most favourably and to validate the model presented above. 
 
 
5.3.3. FREE ENERGY CALCULATIONS 
The model of inhibitor binding presented here must be validated against experimental inhibition 
constants data. Relative free energies of inhibitor binding, ∆∆Abinding, should mirror the trend 
observed in the Ki values. 1d displays the strongest binding and, therefore, should have a more 
favourable absolute free energy of binding than 1c. Consequently, ∆∆Abinding should be positive 
for the mutation of 1d to 1c. Likewise ∆∆Abinding should be positive for the mutation of 1c to 1a. 
Although no inhibition constant has been calculated for 1b, it displays a MshB inhibition that is 














Relative free energies of binding were calculated using the parameterised force field, and protein 
coordinates described above. The results for the forward perturbations (1d to 1a) are presented in 
Table 5-8 and the reverse perturbations (1a to 1d) are presented in Table 5-9. PCA in Chapter 5.2 
identified two favourable conformations for each of 1c and 1d in solution. These conformations, 
annotated by (i) and (ii), had the phenylthio group proximal to each face of the plumbagin, and 
were used to construct the hybrids for the 1d to 1c, 1c to 1b and 1c to 1d transformations in 
water. The signs of ∆∆binding converge in the forward and reverse directions for all calculations. 
However, the results are not in accordance with the experimental data, and show that 1c binds 
more favourably than 1d, and 1a has binds more favourably than 1b. This could be a result of 
two sources of error in the free energy simulations. Firstly errors in the free energy calculations 
may arise from deficiencies in the force field. However, the CHARMM-27 force field is well 
established and missing parameters were carefully calculated from QM calculations. It is not 
envisaged that the deficiencies in the force field would result in such large deviation from the 
experimental data. A second source of error could be that the simulation length was too short and 
led to insufficient sampling of the conformational space. 
 
However, beyond the simulation errors the analysis of the IEs above (Section 5.4.3) showed that 
the differences in inhibitor IEs do no arise from specific interactions enabled by a longer linker. 
TABLE 5-8 Free energy results for the transformation in which a methylene group is removed.  Roman numerals specify the hybrids 







1d (16.8 ± 1.9μM)-1c (94 ± 11μM) -2.14 -1.06 
1c (94 ± 11μM)-1b 0.93 1.29 
1b-1a (167± 15μM) -1.78 
 
 
TABLE 5-9 Free Energy results for the transformation in which a methylene group is added. Roman numerals specify the hybrids 






1c (94 ± 11μM)-1d (16.8 ± 1.9μM) 1.15 1.20 
1b-1c (94 ± 11μM) -2.11 
 













This observation prompted re-evaluation of the initial coordinates before errors in the free energy 
simulations were reduced.  
 
 
5.4. RE-MODELLING INHIBITOR BINDING WITH MSHB 
When reconsidering the initial coordinates, the plumbagin and alkyl linker geometry was 
examined, since GlcNAc binding was assumed to be the same as for the natural substrate. 
Analysis of solution dynamics showed significant interaction between the plumbagin and 
phenylthio groups in 1c and 1d (Chapter 5.2). Therefore, it was decided to re-dock these 
inhibitors so that their geometries were consistent with their favourable conformations in 
solution. 
 
5.4.1. DOCKING AND MOLECULAR DYNAMICS 
In Section 5.2, PCA was conducted on the MD simulation of the inhibitor series in solution. The 
distance between the COM of the phenylthio and plumbagin moieties was used as the principal 
component. The centres of the most populated clusters for 1c and 1d showed two distinct 
conformations, annotated (i) and (ii). These conformations had the phenylthio group proximal to 
each face of the plumbagin. The most populated cluster centres for 1b showed interaction with 
the same plumbagin face despite starting from conformations with different relative plumbagin 
orientations. Therefore, the linker was built onto the GlcNAc fragment in the MshB active site, 
such that the linker dihedrals were the same as the favoured conformations from the solution 
dynamics of 1b, 1c(i), 1c(ii), 1d(i) and 1d(ii) respectively (Section 5.2). The docked 
conformation of 1d(ii) is compared with the previous starting conformation in Figure 5-19. The 
poses were refined in Glide [11] using the same grid generated for previous docking studies 
(Section 5.1.3). The systems were then solvated and subjected to 5ns stochastic boundary 
dynamics. The RMSD time series are given in Figure E-1 (Appendix E) and the average IEs for 












interaction with all the other atoms in the system are given in Figure 5-20. 1c(ii) and 1d(ii), 
which have a relative orientation of their plumbagin and phenylthio groups that is similar to 





FIGURE 5-19 Re-docked conformation of 1d(ii)  with carbon atoms show in purple. The previous orientation with the plumbagin 


































5.4.2. FREE ENERGY CALCULATIONS 
1b, 1c(ii) and 1d(ii) were used as starting structures for new free energy calculations in the 
direction of 1d to 1a. (Reactions in the reverse direction to test for convergence have not been 
calculated). The results are given in table Table 5-10. These results compare much more 
favourably with the experimental Ki data. The relative free energies show that 1d binds more 
favourably than 1c, and 1c bind more favourably than 1a. The remaining mutation, 1c to 1b, has 
a smaller ∆∆Abinding, which is also consistent with the percentage MshB inhibition at 500μM 
concentrations of the inhibitors (81.4% and 81.6% respectively).  
 
 
5.4.3. TRAJECTORY ANALYSIS 
Having achieved satisfactory agreement with experimental data, a preliminary analysis of the 
models was conducted to identify key interactions. Again the phenyl thioglycoside IEs are 
variable with a difference of 9.09kcal/mol between 1c and 1d. The unnormalised linker 
interactions as well as the plumbagin interactions increase with the number of linker atoms. The 
plumbagin MshB interactions of 1c and 1d are similar, but there is a difference of 4.17kcal/mol 




TABLE 5-10 Free energy results for the transformation in which a methylene group is removed. Ki values for the respective inhibitors 
are given in brackets. 
Transformation ∆∆A 
1d (16.8 ± 1.9 μM)-1c (94 ± 11 μM) 1.92 
1c (94 ± 11 μM)-1b 0.88 














The binding of the inhibitors are summarised in Figure 5-21 to Figure 5-23. In all instances the 2 
-acylamido glucose binding is the same as previously modelled. Zn
2+
 coordinates the amide 
linker in accordance with the proposed catalytic mechanism. The C-3 hydroxyl oxygen is 
hydrogen bonded to Arg68, the 4-C hydroxyl group is hydrogen bonded to Arg68 and Asp95, 
and the C-6 hydroxyl oxygen is hydrogen bonded to Asp95. The binding of the hydrophobic 
alkyl linker and C-3 methyl group is mediated by non-polar interactions with a hydrophobic 
pocket composed of Leu19, Leu259, Leu263, Leu265 and Pro209. Improved contact of these 
residues with a larger non-polar surface provided by longer linkers may contribute to more 
favourable binding reported in the free energy calculations.  
 
TABLE 5-11 Average IEs between inhibitor moieties and MshB residues. All energies are reported in kcal/mol, and the sum of the 
energies (Total) are compared with interaction of the entire inhibitor with MshB (MshB). 
Moiety 
1b(ii) 1c(ii) 1d(ii) 
Total VDW ELEC Total VDW ELEC Total VDW ELEC 
Amidoglucose -117.41 -3.07 -114.34 -108.12 -3.74 -104.38 -115.86 -3.04 -112.82 
Phenylthio -2.36 -4.33 1.97 -7.14 -5.80 -1.34 -8.49 -7.31 -1.17 
Linker -5.88 -3.49 -2.39 -7.34 -4.73 -2.62 -8.00 -5.53 -2.47 
Plumbagin -9.82 -9.08 -0.75 -19.03 -13.73 -5.30 -20.70 -16.53 -4.17 
Total -135.47 -19.96 -115.51 -141.63 -28.00 -113.64 -153.04 -32.41 -120.63 




TABLE 5-12 Average IEs between inhibitor moieties and all remaining atoms in the system. All energies are reported in kcal/mol, and 
the sum of the energies (Total) are compared with interaction of the entire inhibitor with all atoms (All).  
 
1b(ii) 1c(ii) 1d(ii) 
Total VDW ELEC Total VDW ELEC Total VDW ELEC 
Amidoglucose -119.54 -2.81 -116.73 -121.78 -2.60 -119.18 -123.90 -3.53 -120.37 
Phenylthio -11.32 -9.98 -1.34 -14.12 -11.88 -2.24 -14.98 -13.28 -1.70 
Linker -7.50 -5.51 -1.99 -9.73 -7.77 -1.96 -11.67 -9.88 -1.80 
Plumbagin -28.50 -18.43 -10.07 -31.06 -20.55 -10.50 -36.94 -22.20 -14.75 
Total -166.86 -36.73 -130.13 -176.69 -42.80 -133.89 -187.49 -48.89 -138.60 













The plumbagin moiety lies next to Tyr142 in all inhibitors and is close to Ile214 in 1c and 1d. In 
1b, the aromatic atoms of the plumbagin group lie parallel to the phenylthio group, and show a T-
like geometry with the Tyr142 aromatic ring. In 1c and 1d the thioglycoside linkage has rotated 
to its second minima (adiabatic map is given in Figure 5-5) and the phenyl ring shows stacking 
orientation with His144. To explore differences in binding of these two residues, the distance 
between the COM of their side chains and the inhibitors were calculated over the last 1ns of the 
trajectory. Figure 5-24 correlates these distance time series with their associated IEs. It is 
observed that the phenylthio group lies far from His144 in 1b and displays a weak IE. The inter-
residue distance in 1c and 1d is much closer, and leads to a stable interaction in 1d. However, 
fluctuation in the 1c-histidine IE, shows that this interaction is not as stable. In the above 
geometry the plumbagin group of 1c and 1d maximises surface contact with Tyr142. 
Unfortunately, time did not allow for vector analysis of their relative orientations which is 
important for characterising π-stacking interactions. The COM distance and IE time series for the 
Tyr142-inhibitor interactions are reported in Figure 5-24, and show that the proximity of the two 
hydrophobic groups gives rise to a stronger IE in 1c and 1d. The more favourable interaction 
between His144 and Tyr142 contribute to an improved MshB interaction in 1c and 1d. It is 
suggested that these interaction are facilitated by a longer linker, which imparts more flexibility 
to the C-2 acylamido side chain. A more in depth analysis is required to confirm this hypothesis, 















FIGURE 5-21 (A) 2D illustration summarising the binding of 1b with MshB. (B) Snapshot showing important hydrogen bonding and 
hydrophobic interactions. Polar MshB residues are shown with green carbons, while hydrophobic residues are shown 
















FIGURE 5-22 (A) 2D illustration summarising the binding of 1c with MshB. (B) Snapshot showing importatnt hydrogen bonding and 
hydrophobic interactions. Polar MshB residues are shown with green carbons, while hydrophobic residues are shown 
















FIGURE 5-23 (A) 2D illustration summarising the binding of 1d with MshB. (B) Snapshot showing important hydrogen bonding and 
hydrophobic interactions. Polar MshB residues are shown with green carbons, while hydrophobic residues are shown 





















FIGURE 5-24 (A, C & E) Time series for distance between the COM of the phenylthio group and His144 side chain.  (B, D & F) IE 






















5.5. RATIONALISATION OF INHIBITION 
It is not clear from the results of the MD simulations how the plumbagin conjugates inhibit 
MshB. MshB has known amidase activity with a range of substrates [22, 23], which is foreseen to 
proceed via the same proposed catalytic mechanism for the deacetylation of GlcNAc-Ins. The 
equilibrated structures discussed above have the C-2 amido carbonyl coordinated to zinc at the 
same coordination site as that modelled for the natural substrate. In this conformation the zinc-
coordinated water lies close to the proposed general base Asp15, and the water molecule would 
be in a good position to attack the amide linkage after abstraction of its hydrogen. It could be that 
the inhibitors are acting as competing substrates rather than inhibiting the amidase activity of 
MshB. Difficulty in obtaining a co-crystallised structure with 1d supports is in agreement with 
the hypothesis. It would therefore be pertinent to repeat the inhibition assays and test for the 
presence of GlcN-SPh.  
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CONCLUSIONS AND FUTURE WORK 
This research has provided insight into the competitive inhibition of MshB by substrate-based 
analogues synthesised by Gammon et al. [1]. Neither inhibitor nor substrate analogue has been 
co-crystallised with MshB, and the natural substrate binding is uncertain. Therefore, the binding 
site was characterised and showed a large hydrophobic cavity adjacent to the putative active site. 
The results of docking calculations were in accordance with previous models of the GlcNAc 
fragment, and with the proposed catalytic mechanism. Atomistic MD simulations of the docked 
pose elucidated hydrophobic interactions between D-myo-inositol and Met98, as well as between 
the C-2 acetamido group and Leu259.  
 
The inhibitors were docked having the same glucose orientation as the natural substrate. The 
systems were equilibrated and used as starting points for free energy simulations. The inhibitors 
were ranked according to their relative free energy of binding, and the ranking was compared to 
experimental Ki values. The results indicated that the binding mode is not one which would be 
expected given the landscape of the MshB binding pocket.  
 
Initial docking studies yielded conformations with C-2 acylamido side chain extending linearly 
from the glucose moiety, into the hydrophobic cavity adjacent to the putative active site. This 
appeared plausible due to the glucose orientation, and the complementary nature of the 
hydrophobic linker and plumbagin groups with the cavity. However, free energy results using the 
above conformations did not reproduce the experimental ranking. Analysis of the MshB-inhibitor 
interactions showed that, in these models, a longer alkyl spacer did not enable more favourable 
interactions. This prompted re-evaluation of the starting coordinates.  
 
PCA studies of the inhibitor dynamics in solution had revealed hydrophobic interaction 












of 1b, 1c and 1d. These conformations were docked with the MshB active site and the free 
energy calculations were repeated. The ranking of the inhibitors based on the new relative free 
energies of binding were in agreement with the experimental ranking. Due to the timeframe of 
this dissertation free energy transformations were only run from 1d to 1a. It is necessary to run 
the calculations in the reverse direction, and for longer periods, in order to test for convergence. 
Preliminary analysis of the MD trajectories showed that the longer linker facilitated more flexible 
interactions with His144 and Tyr142. Future work requires a more detailed analysis of the 
enthalpic and entropic contributions to inhibitor binding, as well as investigation of the 
hydrophobic interactions between the plumbagin and phenylthio groups.  
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APPENDIX A: DEPENDENCE OF FREE ENERGY OF  FOR 
TI AND FEP METHODS 
 
FIGURE A-1 Dependence of free energy on  for the transformation of 1d to 1c using TI. (A) 1d(i) to 1c in water. (B) 1d(ii) to 1c in 
water. (C) 1d to 1c at the MshB active site. (D) 1d(ii) to 1c at the MshB active site. The dependence of free energy on  



















FIGURE A-2 Dependence of free energy on  for the transformation of 1d-1c using FEP. (A) 1d to 1c at the MshB active site. (B) 1d to 
1c in water. Plots were taken from early work. Different curves on the plots represent results after different equilibration 
times. A large change in free energy is observed with change in  at the end-points (0 to 0.1 and 0.9 to 1), which indicates 















APPENDIX B: ANALYSIS OF Φ AND Ψ DURING 








FIGURE B-1 (A & C) θ,ψ scatter plot for 1a and 1b over the 2.5ns trajectory. (B & D) ψ time series. The plots show that the 

















FIGURE B-2 (A & C) θ,ψ scatter plot for 1c and 1d over the 2.5ns trajectory. (B & D) ψ time series. The plots show that the 
















APPENDIX C: RMSD TIME SERIES FOR MSHB-

















APPENDIX D: TIME SERIES OF IES AND DISTANCES 
BETWEEN COMS FOR INTERACTION PAIRS IN THE 
MSHB-INHIBITOR COMPLEXES 
1A 
INTERACTIONS OF THE PHENYLTHIO GROUP 
  
FIGURE D-1 Distance between COM of the phenylthio group of 1a and the amino acid side chains indicated in the legends. In the case 








































INTERACTION OF THE PLUMBAGIN METHYL GROUP 
 
 




INTERACTIONS OF THE PHENYLTHIO GROUP 
 
 
























FIGURE D-6 Distance between COM of the alkyl linker of 1b and the amino acid side chains indicated in the legends.  
 
 





















INTERACTIONS OF THE PLUMBAGIN AROMATIC ATOMS 
  



















FIGURE D-9 Distance between COM of the phenylthio group of 1c and the amino acid sides chain indicated in the legends. In the case 

























FIGURE D-10   Distance between COM of the alkyl linker of 1c and the amino acid side chains indicated in the legends.  
 
 
INTERACTIONS OF THE PLUMBAGIN METHYL GROUP 
  
  












































INTERACTIONS OF THE PHENYLTHIO GROUP 
  
FIGURE D-13 Distance between COM of the phenylthio group of 1d and the amino acid side chains indicated in the legends. In the case 




















































































































FIGURE D-17 (A) Total IE of 1c with all atoms in the system, and (B) distance time series for the 8-C-hydroxyl hydrogen and the oxygen 


























FIGURE D-18 (A, C & E) Time series for the distance between the COM of the phenylthio groups of the inhibitors and the amino 
acid side chain specified. (B, D & F) IE of the amino acid residues with the inhibitors. Hydrogen bond analysis showed that 
the decrease in IE of 1c with His144 corresponded with the formation of a hydrogen bond between the C-6 hydroxyl 























FIGURE D-19 (A, C & E) Time series for distance between the COM of the plumbagin greoups of the inhibitors and the amino acid side 

























FIGURE E-1 RMSD time series for inhibitors with the revised conformation of binding. The RMSD was calculated for all amino acid 
residues which had an atom within 8Å from the respective inhibitor specified in the legend. 
